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Transcriptional Control Of Circadian Rhythms
Abstract
The daily rotation of the Earth around its axis generates a light-day cycle that occurs every 24 hours. To
cope with this environmental stress, every photosensitive organism has evolved with circadian rhythms to
anticipate and adapt to recurring changes in the environment. Circadian rhythms are pervasive features in
biology and nearly all cells have their own clocks, which coordinate various aspects of mammalian
physiology, including sleep, behavior, and metabolism throughout the day. My thesis work aimed to
dissect the molecular mechanism by which circadian rhythms are transcriptionally controlled. More
specifically, we investigated how the core clock transcriptional factor Rev-erbα regulates enhancerpromoters loops to repress circadian gene transcription. We demonstrate that as a transcriptional
repressor, Rev-erbα opposes enhancer-promoter loops in a circadian manner by evicting chromatinassociated factors involved in looping, thus revealing genome-wide plasticity of 3D chromatin
organization. Broadly, this mechanism of action may be generalizable to other transcriptional repressors,
including nuclear receptors. In addition, we also sought to characterize circadian transcriptional
regulation by an unknown ETS transcription factor. From an unbiased approach, we identified the ETS
transcription factor GABPα, which exhibited a circadian rhythm of nascent transcription at its cistrome
despite no circadian change in its genomic occupancy. Genetic knock out of GABPα led to phenotypes
and patterns of differential gene expression resembling cellular senescence likely due to mitochondrial
dysfunction. Interestingly, we observed that GABPα knock out gave rise to a pathologic circadian rhythm
of the senescence-associated secretory phenotype gene program. Taken together, my thesis work has
provided a novel insight into how circadian rhythms are transcriptionally coordinated by complex
interplays among the genome, transcription factors, and other chromatin-associated factors.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Cell & Molecular Biology

First Advisor
Mitchell A. Lazar

Keywords
Circadian rhythm, Epigenetics, Gene regulation, Genetics, Physiology, Transcription

Subject Categories
Genetics | Molecular Biology | Physiology

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/3048

TRANSCRIPTIONAL CONTROL OF CIRCADIAN RHYTHMS
Yong Hoon Kim
A DISSERTATION
in
Cell and Molecular Biology
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2018

Supervisor of Dissertation
________________________
Mitchell A. Lazar, M.D., Ph.D.
Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases

Graduate Group Chairperson
________________________
Daniel Kessler, Ph.D.
Associate Professor of Cell and Developmental Biology

Dissertation Committee
Zoltan P. Arany, M.D., Ph.D., Associate Professor of Medicine
Gerd A. Blobel, M.D., Ph.D., Frank E. Weise III Professor of Pediatrics
Liming Pei, Ph.D., Assistant Professor of Pathology and Laboratory Medicine
Golnaz Vahedi, Ph.D., Assistant Professor of Genetics

TRANSCRIPTIONAL CONTROL OF CIRCADIAN RHYTHMS

COPYRIGHT
2018
Yong Hoon Kim

This work is licensed under the
Creative Commons AttributionNonCommercial-ShareAlike 3.0
License
To view a copy of this license, visit

https://creativecommons.org/licenses/by-nc-sa/3.0/us/

To my family for their unwavering love and support

iii

ACKNOWLEDGEMENT
First and foremost, I would like to thank my mentor Dr. Mitch Lazar for his guidance and
encouragement throughout my doctoral training. Mitch embodies the true spirit of being a
scientist: curiosity, creativity and persistence in his lifelong dedication to pursuit of the truth. His
mature insight into science has constantly challenged me to think critically and test my hypothesis
rigorously, while his infectious passion for science has inspired me to imagine creatively about
the unknown. He has truly been an extraordinary role model I aspire to emulate throughout my
career.
I would also like to thank my thesis committee, Drs. Gerd Blobel, Zolt Arany, Liming Pei,
and Golnaz Vahedi for their invaluable feedback, constructive criticism and continuous support. I
would also like to thank other external advisors, including Dr. Toms Jongens and Meagan
Schofer of the CAMB-G&E program, Drs. Douglas Epstein and Meera Sundaram of the Genetics
Predoctoral Training Grant, and Dr. Skip Brass, Maggie Krall, and David Bittner of the Penn
MSTP, for their guidance throughout graduate school and medical school.
The Lazar lab has been both an incredibly fun and supportive environment to do science.
I cannot thank enough all the past and current members of the lab, including Dave Steger,
Wesley Ho, Joe Weaver, Lindsey Peed, Erika Briggs, Marine Adlanmerini, PJ Dierickx, David Hill,
Amy Hauck, Yehuda Shabtai, Chunjie Jiang, Romeo Papazyan, Ray Soccio, Paul Tichenell,
Yuxiang Zhang, Jennifer Jager, Sean Armour, Jarrett Remsberg, Matt Emmett, Daniel Cohen, Bin
Fang, Tori Nelson, Kavya Chegireddy Manashree Damle, and Hannah Richter. It has been my
great honor to work with so many intelligent, warm and passionate people on a daily basis.
I would also like to thank other friends and colleagues in the IDOM and graduate school,
including Suzi Shapira, Alex Sakers, Anthony Angueira and Megan Coyle of the Seal Lab, Aoi
Wakabayashi and Jen Myer SanMiguel of the CAMB-GE program, Rebecca Gelfer of the
Tichenell lab, Amber Wang, Kristy Ou and Ayano Kondo of the Kaestner lab, and Sajid Marhon
and Hee-Woong of the Won Lab, I am truly grateful for their friendship and support.

iv

I would like to extend my special thanks to my friends and mentors from the past and
present. Drs. Ting-Ting Wu and Seungmin Hwang for instilling in me a passion for science during
my undergraduate years. Eric Lesh for being a true buddy who has always been there for me
during our fun adventures and during my difficult times. I am fortunate to have met so many
incredible and talented friends in medical school. Leo Wang for being stupid with me most of the
time and being real with me sometimes when I needed to. Mike Werner for sharing our ideals
about the world over many dozens of oysters. Jon Kotzin and Alan Tang for reminding me why
we are still passionate about science even after all these years. And Robert and Leela Dilley for
the countless laughter and tears we shared and for being a constant source of inspiration and
heartwarming support.
Last but not least, I would like to thank my family, Mom (um-mah), Dad (a-ppah), and Sis
(nu-nah). I consider myself the luckiest person for being born to my loving family. I was able to
pursue my dreams and ambitions only because of the endless love and support they have given
me throughout my life. They have always believed in me even when I doubted myself. They have
also inspired me with the perseverance, sacrifice, and dedication they have shown at times when
things got tough and when it was tempting to just give up. From my family, I learned to be
passionate, learned to work hard, and learned to love and care for others. For all that you have
been in my life, I thank you and love you.

v

ABSTRACT
TRANSCRIPTIONAL CONTROL OF CIRCADIAN RHYTHMS
Yong Hoon Kim
Mitchell A. Lazar, M.D., Ph.D.
The daily rotation of the Earth around its axis generates a light-day cycle that occurs
every 24 hours. To cope with this environmental stress, every photosensitive organism has
evolved with circadian rhythms to anticipate and adapt to recurring changes in the environment.
Circadian rhythms are pervasive features in biology and nearly all cells have their own clocks,
which coordinate various aspects of mammalian physiology, including sleep, behavior, and
metabolism throughout the day. My thesis work aimed to dissect the molecular mechanism by
which circadian rhythms are transcriptionally controlled. More specifically, we investigated how
the core clock transcriptional factor Rev-erbα regulates enhancer-promoters loops to repress
circadian gene transcription. We demonstrate that as a transcriptional repressor, Rev-erbα
opposes enhancer-promoter loops in a circadian manner by evicting chromatin-associated factors
involved in looping, thus revealing genome-wide plasticity of 3D chromatin organization. Broadly,
this mechanism of action may be generalizable to other transcriptional repressors, including
nuclear receptors. In addition, we also sought to characterize circadian transcriptional regulation
by an unknown ETS transcription factor. From an unbiased approach, we identified the ETS
transcription factor GABPα, which exhibited a circadian rhythm of nascent transcription at its
cistrome despite no circadian change in its genomic occupancy. Genetic knock out of GABPα led
to phenotypes and patterns of differential gene expression resembling cellular senescence likely
due to mitochondrial dysfunction. Interestingly, we observed that GABPα knock out gave rise to a
pathologic circadian rhythm of the senescence-associated secretory phenotype gene program.
Taken together, my thesis work has provided a novel insight into how circadian rhythms are
transcriptionally coordinated by complex interplays among the genome, transcription factors, and
other chromatin-associated factors.
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CHAPTER 1: INTRODUCTION

I. Evolutionary Origin of Circadian Rhythms and Historical Perspective

To sustain existence, every living organism must have a plastic means to cope with
evolutionary pressures imposed upon by environmental variations. Positive and negative
selection of inheritable traits drives evolution, which ultimately results in either survival or
extinction of species. Disruptive environmental changes can be gradual or abrupt, allowing the
habitants of an isolated environment to steadily adapt, or rapidly perish or flourish.
The Earth is an inherently dynamic ecosystem due to the daily rotation around its axis.
With each rotation, its surface is exposed to the Sun with varying degrees of intensity that
oscillate every 24 hours, creating a recurring phenomenon which we call “day and night.”
Circadian (in Latin, “circa” = around, “dian” = day) variations of sunlight pose a formidable
challenge to organisms due to drastic environmental shifts that occur on a daily basis. From an
evolutionary perspective, these external variations exert a selective pressure distinct from those
by single disruptive perturbations, in which one or few favorable phenotypes are selectively
propagated. More specifically, phenotypes that arise in response to circadian variations in the
environment require temporal variability, such that beneficial variations emerge only during
certain hours of the day, but not at other times when these adaptations are not favored, or even
detrimental if present. They also require predictable recurrence, as the environment changes over
the course of 24 hours and repeats the same cycle the next day. As such, phenotypic variations
functionally tied to the rotation of the Earth have emerged with circadian rhythmicity to maximize
organismal fitness on a 24-hour time scale. It is on this evolutionary basis that nearly all aspects
of fundamental biological functions are coupled with the rising and setting of the Sun (Pittendrigh,
1993).
The earliest evidence of the circadian clock is found in cyanobacteria, the first
prokaryotes capable of oxygen-producing photosynthesis. Among the oldest organisms,
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cyanobacteria are also one of the most successful organisms that predominated the Earth’s
ecosystem over 2.5 billion years, a period known as “the Age of Cyanobacteria.” (Schopf, 1996)
The ecological success of these prokaryotes attests to evolutionary advantages conferred by the
early adaptation of circadian clock genes that instructed the temporal organization of
photosynthesis, which enabled cyanobacteria to anticipate daily light-dark cycles and thus carry
out photochemical reactions more efficiently. The circadian rhythms of cyanobacteria are
controlled by a cluster of three adjacently clock genes, called kaiA, kaiB, and kaiC (In Japanense,
“Kai” = rotation) (Ishiura et al., 1998). The protein products of these genes regulate one another
in an autoregulatory negative transcriptional and translational feedback loop, which generates
circadian patterns of expression and function (Ishiura et al., 1998). Phylogenetic studies have
revealed that this cluster is highly conserved in various cyanobacterial species and also
extremely ancient: the kaiB-C cluster is estimated to have originated as 3,500-2,320 million years
ago, with kaiA added to the cluster much later (Dvornyk et al., 2003). Functional genetic studies
subsequently demonstrated that this cluster governs other key physiological processes of
cyanobacteria, such as nitrogen fixation and cell division, suggesting this circadian clock further
evolved to play an all-encompassing role in the survival of cyanobacteria (Chen et al., 1998;
Johnson and Golden, 1999; Mori et al., 1996). Despite the pre-historic origin of circadian rhythms,
the first written observation about intrinsic timekeeping mechanisms was not made until in the late
th

18 century. The French scientist Jean-Jacques d’Ortous de Mairan noticed that opening and
closing movements of the Mimosa pudica plant leaves occurred in a circadian manner in
synchrony with the Sun. To test if this daily behavior was triggered by light, he put the plant aside
from the window and kept in constant darkness. To his amazement, leaf movement persisted
even in the absence of light, and he thereby concluded that this behavior was autonomously
driven by an endogenous clock functioning independently of light (de Mairan, 1792). Nearly two
centuries later, Seymour Benzer and his student Ronald Konopka first demonstrated the genetic
basis of intrinsic timekeeping mechanisms. Using the Drosphila melanogaster as a model
organism, they isolated three clock mutants collectively called Period (Per) that exhibited
arrhythmic behaviors in eclosion and locomotor activity (Konopka and Benzer, 1971). This finding
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was seminal not only because it demonstrated that the endogenous clock was encoded in the
genome, but also because it proposed the profound concept that genes control phenotypes as
complex as behavior. About a decade later, the identity of the Period gene was finally demystified
through elegant molecular cloning and genetic experiments conducted in the laboratories of
Jeffrey Hall, Michael Rosbach and Michael Young (Bargiello and Young, 1984; Bargiello et al.,
1984; Reddy et al., 1984; Zehring et al., 1984). For their scientific contributions elucidating the
molecular mechanisms controlling circadian rhythms, these three American scientists were
awarded the 2017 Nobel Prize in Physiology and Medicine.
Since the initial discovery and molecular cloning of the Period gene, it is now well
appreciated that essentially all photosensitive forms of life on the Earth exhibit circadian rhythms
of cellular and organismal functions (Lowrey and Takahashi, 2004; Takahashi et al., 2008). Over
the past few decades, many other genes that constitute the molecular clock have been cloned
and characterized in different species. However, while major players have been placed on the
clock field, fundamental questions still remain as to how these molecular cogs function together to
keep the clock ticking, particularly at the level of systems regulation (Papazyan et al., 2016a;
Takahashi, 2016). In the recent years, the advent of genome-wide analysis techniques and
genome-editing tools has offered us a tangible opportunity to functionally tease apart the clock
with a magnitude, speed and precision that have not been afforded in the past. With the promise
of the new technologies and ever expanding computational arsenals to decode complex network
systems such as the molecular clock, we are entering a truly exciting time in which elusive ideas
in circadian biology are becoming tractable questions.
In this thesis, I will explore the ways in which we have employed several genome-wide
and systems approaches to explore the transcriptional control of circadian rhythms, and discuss
experimental results as well as our interpretations that provided a novel insight into the
mechanism of the molecular clock.
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II. Mammalian Molecular Clock and Its Relevance to Human Health and Disease
Transcriptional Regulation of the Molecular Clock
The mammalian clock is orchestrated by transcriptional activators and repressors
interlocked in autoregulatory negative feedback loops that generate cell-autonomous rhythms of
oscillating transcription and translation, a central governing principle underlying all molecular
clocks (Alon, 2007; Takahashi, 2016). Broadly, the mammalian clock consists of a positive limb
that drives three major regulatory limbs, which control the circadian expression of the positive
limb in both independent and co-dependent manners.
The positive limb of the mammalian clock is driven by three basic helix-loop helix (bHLH)
domain-containing transcription factors: Bmal1 (Brain And Muscle ARNT-like 1; encoded by
Arntl), Clock (Circadian Locomotor Output Cycles Kaput) and Npas2 (Neuronal PAS domain
protein 2; a paralog of Clock) (Bunger et al., 2000; Debruyne et al., 2007; King et al., 1997;
Vitaterna et al., 1994; Zhou et al., 1997). Bmal1 forms heterodimeric complexes with either Clock
or Npas2 and binds to promoters and enhancers containing E-box motifs to stimulate the
expression of other core clock transcription factors that constitute the negative limbs of the clock.
The first regulatory limb consists of Per and Cry proteins, whose homologous genes also
have clock functions in the Drosphila melanogaster, albeit working through discrete molecular
mechanisms in the two eukaryotic systems (Emery et al., 1998). In the mammalian system, the
Per and Cry proteins form heterodimeric complexes and are phosphorylated by casein kinase I
(CKIε/δ) in the cytoplasm prior to translocating into the nucleus, wherein they bind Bmal1Clock/Npas2 heterodimers to repress the transcription of Bmal1-target genes including their own,
thus establishing a negative feedback loop at the level of Bmal1 transcriptional activity (Albrecht
et al., 1997; Griffin et al., 1999; Lee et al., 2001; Sun et al., 1997).
The second regulatory limb is controlled by the nuclear hormone receptor transcription
factors RAR-related orphan receptor (ROR) α/β/γ (encoded by RORA, RORB and RORC) and
Rev-erbα/β (encoded by NR1D1 and NR1D2) (Lazar et al., 1989; Preitner et al., 2002; Sato et al.,
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2004). The ROR and Rev-erb proteins recognize the common consensus motifs, RORE and
RevDR2 (Giguere et al., 1995; Harding and Lazar, 1995). These proteins compete for the same
biding sites where RORs activate transcription and Rev-erbs repress transcription. Bmal1
heterodimers together with Per-Cry heterodimers drive the circadian expression of Rev-erbα and
β, which then rhythmically compete with RORs throughout the genome. One of these targets is
the Bmal1 promoter, thus establishing a negative feedback loop at the level of Bmal1
transcription (Bugge et al., 2012; Cho et al., 2012; Preitner et al., 2002). In addition, Rev-erbs
bind to an intronic enhancer in the Cry1 locus to repress transcription, which induces a phase
delay critical for fine-tuning the first negative feedback loop (Ukai-Tadenuma et al., 2011).
The third regulatory limb is established by the proline and acidic amino acid rich basic
leucine zipper (PAR-bZIP) transcription factors: DBP (D-binding protein), TEF (thyrotroph
embryonic factor), HLF (hepatic leukaemic factor) and Nfil3/E4bp4 (nuclear factor, interleukin-3
regulated/E4 Promoter Binding Factor 4; encoded by NFIL3) (Gachon et al., 2004; Mitsui et al.,
2001). They all recognize and compete for promoters and enhancers containing D-box motifs
where DBP, TEF and HLF activate transcription in a redundant manner, while Nfil3 represses
transcription. The circadian activity of this loop primarily stems from the circadian expression of
DBP and TEF driven by Bmal1 heterodimers (Hatanaka et al., 2010; Stratmann et al., 2012). In
addition, this negative limb is also under the control of the ROR-Rev-erb loop. At the peak of DBP
and TEF expression, Rev-erbs simultaneously repress the transcription of Nfil3, allowing both
activator PAR-bZIP proteins to maximally induce transcription in the absence of their repressive
competitor (Fang et al., 2014). The rhythmic competition between these activator PAR-bZIP
proteins and the repressor Nfil3 subsequently drives the circadian expression of RORγ, which
then peaks at the troughs of Rev-erb α/β expression (Yu et al., 2013). While this loop does not
directly control the positive limb, it reinforces the second regulatory loop by diurnally separating
transcriptional activation by RORs and transcriptional repression by Rev-erbs in opposite phases.
Together, these autoregulatory loops generate a cell-autonomous rhythm of the core
clock genes as well as other clock-controlled genes at the transcription level. The circadian
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regulation of transcription is a pervasive feature in nearly all cells. For any given cell or tissue, 520% of its transcriptome undergoes circadian oscillations at the steady-state mRNA level (Zhang
et al., 2014). Interestingly, only a small fraction of oscillating mRNA transcripts (20-25%) show
circadian rhythms at the nascent transcription level, suggesting that extensive post-transcriptional
mechanisms also control cellular circadian rhythms (Koike et al., 2012; Menet et al., 2012).
Furthermore, the core clock transcription factors are subject to various post-translational
modifications, which regulate their stability and function (Busino et al., 2007; Lamia et al., 2009;
Yin et al., 2006; Zhao et al., 2016). Therefore, it is important to recognize that, in addition to the
transcriptional network driven by the core clock machinery, multiple layers of post-transcriptional
regulatory modules fine-tune and contribute to the coordination of cellular circadian rhythms.

Hierarchical Organization of the Organismal Clock: the Central and Peripheral Clocks
In the mammalian system, organismal circadian rhythms are hierarchically organized. At
sunrise, incoming light is detected by photosensitive retinal ganglion cells expressing the
photopigment melanopsin, which transform a photic signal into a neuronal action potential (Hattar
et al., 2003; Provencio et al., 1998). The action potential then propagates through the axons of
the optic nerve in the retinohypothalamic track to the suprachiasmatic nucleus (SCN) of the
hypothalamus. The daily activation of the SCN by light serves as the central clock that entrains
organismal circadian rhythms with the environment.
The SCN controls various output pathways in the brain as well as the rest of the body via
neuronal and humoral signals. By simultaneously coupling neuronal networks of the brain and
systemic functions of the peripheral organs, the SCN ensures proper timing of both behavior and
physiological aptitude throughout the day, including sleep-wake cycles, body temperature
fluctuations, feeding patterns and metabolism (Takahashi et al., 2008). Without this central
entrainment, organismal circadian rhythms go awry, as mice kept in the absence of external cues
exhibit free-running patterns that no longer oscillate with a 24-hour period, demonstrating that the
endogenous clocks require the central entrainment to effectively synchronize with the Sun.
While the crosstalk between the central nervous system and the peripheral organs is
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critical for the whole-body entrainment, every tissue and organ also has independent means to
regulate its own clock. A majority of the peripheral organs also express clock genes and exhibit
circadian rhythms of gene expression and functions (Miller et al., 2007; Mure et al., 2018;
Nagoshi et al., 2004). However, different cells and tissues have variations in the composition of
their clock machineries in terms of the relative expression levels of the core clock genes, the
presence or absence of their isoforms, and the phase of their peak expression (Mure et al.,
2018). This implies a potential functional significance of variability in tissue-specific clocks. For
instance, while RORα and γ are expressed in a large array of tissues, RORβ expression is
relatively confined to the central nervous system (André et al., 1998; Forman et al., 1994).
Furthermore, tissue-specific clocks can be independently entrained by physiological and
environmental cues relevant to their functions. The liver clock is predominantly entrained by
feeding and nutrient availability, such that feeding restricted to only certain hours of the day can
rapidly reset the liver clock without affecting the rhythms of the SCN clock corresponding to the
normal light-dark cycle (Stokkan et al., 2001).
One molecular mechanism controlling the feeding-controlled entrainment is mediated by
AMPK (adenosine-monophosphate-activated protein kinase), a central sensor of metabolic
signals. The kinase activity of AMPK is modulated by an intracellular AMP/ATP ratio, which
reflects the energy status of the cell and is thus tightly controlled by feeding. AMPK has been
shown to phosphorylate the core clock component Cry proteins to target them for degradation,
thus enabling metabolic signals to rewire the molecular clock in the peripheral organs (Lamia et
al., 2009).
Metabolism may also affect other components of the clock, such as Rev-erb proteins.
The repressive action of Rev-erbs is potentiated by their ligand heme (Raghuram et al., 2007; Yin
et al., 2007). Interestingly, heme is synthesized from the amino acid glycine and succinyl-CoA
from the citric acid cycle in highly regulated steps. This potentially suggests that pathways
involved in the syntheses of both metabolites may indirectly influence the clock through heme and
its regulation of Rev-erb activity.
Finally, the peripheral clocks can also regulate one another. In the liver, the ROR-Rev-
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erb loop controls the circadian expression of PPARδ (peroxisome proliferator-activated receptor
delta), which drives diurnal de novo lipogenesis that produces lipid species phosphatidylcholine
18:0/18:1. These metabolites are then secreted into the serum and taken up by the muscle, after
which they serve as ligands for PPARα (peroxisome proliferator-activated receptor alpha) to
promote fatty acid oxidation, thus simultaneously driving anabolism and catabolism in the two
distant metabolic organs in a circadian manner (Liu et al., 2013).
The temporal coupling of mammalian physiology with the environment by the SCN is
important for coordinating stereotyped behaviors and their related physiological functions that
occur daily. However, equally important is the independent ability of the peripheral organs to
override the central entrainment by the SCN, thus establishing a “Checks and Balances” system
within the physiological hierarchy between the central nervous system and the peripheral organs.
This system confers the peripheral organs functional plasticity, with which they can rapidly adapt
to stimuli and mount appropriate and necessary physiological responses regardless of whatever
time of the day. Together, while the central clock homeostatically prepares physiological aptitudes
of the peripheral organs, the peripheral clocks are empowered with dynamic mechanisms to run
at their own paces in order to prioritize and ultimately meet the needs of the organism.

Circadian Rhythms in Human Health and Disease
The notion that circadian rhythms play central roles in physiological homeostasis is
further supported by numerous studies that have demonstrated that both genetic and
environmental perturbations of the clock result in devastating health consequences. In particular,
consistent with the fact that the normal sleep-wake cycle is under the genetic control of the
molecular clock, several mutations in the core clocks genes as well as their regulatory partners
have been linked to human sleep disorders with Mendelian patterns of inheritance.
Familial advanced sleep-phase syndrome (FASPS) is the first genetic disorder that linked
mutations in the core clock genes to human circadian sleep disorders (Jones et al., 1999; Reid et
al., 2001). FASPS is a highly penetrant autosomal dominant disorder that is characterized by a
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lifelong pattern of advanced sleep onset and offset by 3-4 hours earlier than conventionally
desired times (e.g. falling asleep at 7:00 p.m. and waking up at 4:00 a.m.). The first genetic
linkage analysis mapped the human Per2 gene as the causal locus in chromosome 2q, where a
point mutation that substituted a serine at amino acid 662 with a glycine (S662G) was identified
(Toh et al., 2001). Interestingly, this serine residue occurred at a phosphorylation site within a
domain of human Per2 protein that was bound by CKI and regulated by its kinase activity.
Subsequent mouse genetic and biochemical studies demonstrated that this mutation led to
reduced nuclear retention of the protein, potentially due to enhanced proteasome-mediated
degradation (Vanselow et al., 2006; Xu et al., 2007). In support of with this model, another human
mutation linked to FASPS has been found in the CKIδ gene, which resulted in a missense
mutation (T44A) that abolished the kinase activity of the protein, thereby mechanistically and
functionally phenocopying the S662G mutation (Xu et al., 2005).
Delayed sleep phase disorder (DSPD) is another sleep disorder that has been linked to
mutations in the core clock genes. Opposite to FASPS, patients affected with DSPD are
considered “night owls,” characterized by late onset and offset of sleep (e.g. falling asleep at 3:00
a.m. and waking up at 11:00 a.m.). Unlike FASPD, DSPD is more prevalent in the general
population and has been postulated to result from more heterogeneous etiologies given the
diverse manifestations of the disorder, even though twin studies have also revealed a strong
hereditary component in chronotype preference and thus argued in favor of genetic predisposition
for DSPD pathogenesis (Ancoli-Israel et al., 2009; Barclay et al., 2010; Koskenvuo et al., 2007;
Sack et al., 2007; Vink et al., 2001). Several population studies have found potential associations
between DSPD and genetic variants in the core clock genes, such as T3111C polymorphism in
the 3′ un-translated region (UTR) of CLOCK and a single nucleotide polymorphism in the 5′-UTR
of PER2 (Carpen et al., 2005; Iwase et al., 2002; Mishima et al., 2005). However, the causality of
these associations has not yet been proven and thus warrants further genetic and biochemical
investigations.
Recently, a case of familial DSDP has been attributed to a dominant coding variant in
CRY1 (Patke et al., 2017). This variant, an adenine-to-cytosine variant within the 5’ splice site
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following exon 11 at +3 intronic position (c.1657+3A>C), disrupted splicing and caused skipping
of exon 11, generating a truncated transcript with an in-frame deletion of 24 residues encoded in
the C-terminal domain. The truncated transcript produced a gain-of-function protein variant with a
stronger repressive activity due to enhanced interactions with Bmal1 and Clock proteins, thus
lengthening circadian period. Interestingly, this variant has been reported to occur with a
frequency between 0.1-0.6%, suggesting that this variant may potentially account for a significant
fraction of DSPD cases with otherwise unknown etiologies.
In addition to these genetic mutations disrupting the clock, circadian rhythms can also be
perturbed by environmental changes. The most common and well-known circadian misalignment
is jetlag disorder, which is an acute and transient form of disruption that manifests as a cohort of
symptoms, including insomnia, excessive sleepiness and decreases in total sleep time (Reid and
Abbott, 2015). Similarly, nocturnal use of electronic devices that emit blue light or staying up late
on weekends, also referred to as “social jetlag,” can cause similar symptoms (Chang et al., 2015;
Roenneberg et al., 2012).
Consistent with the finding that most of genes expressed with circadian rhythms belong
to metabolic pathways, chronic circadian misalignment in humans often results in various
metabolic disturbances (Panda et al., 2002). Human subjects who have been introduced to
controlled circadian misalignment in a laboratory setting exhibited symptoms resembling prediabates, characterized by poor glucose homeostasis, attenuated insulin function, and an overall
decrease in energy expenditure (Buxton et al., 2012; McHill et al., 2014). Furthermore, several
epidemiological studies have demonstrated that nightshift workers, such as nurses and janitorial
staff, who have been chronically exposed to circadian misalignment are at increased risks for
various metabolic diseases as well as cancer (Pan et al., 2011; Schernhammer et al., 2001).
Together, these human genetics and epidemiological studies highlight not only how
circadian rhythms maintain physiology and health, but also how circadian misalignment
contributes to various human pathologies. Furthermore, this underscores an urgent need to better
understand the molecular underpinning of such diseases, which remain largely unexplored to this
day.
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III. Rev-erbα and Mechanisms of Transcriptional Repression by Nuclear Receptors

The Nuclear Receptor Superfamily and Common Mechanisms of Action
The nuclear receptor (NR) superfamily in humans is comprised of 48 transcription factors
that share conserved structural domains and mechanisms of transcriptional control (Mangelsdorf
et al., 1995). The superfamily includes major receptors for sex steroid hormones, thyroid
hormones, vitamin D, xenobiotics and various metabolic intermediates. As such, NRs
transcriptionally regulate various aspects of cellular and physiological functions, including
development, differentiation, metabolism and reproduction (Lazar, 2017). For this reason, NRs
have been major pharmacological targets for a myriad of human diseases; indeed, approximately
13% of all drugs approved by the U.S. Food and Drugs Administration modulate NR activities,
further highlighting the critical roles of NRs in both health and disease (Overington et al., 2006).
At the biochemical and structural level, all NRs show key conserved features that are
carried out by specific modular domains, which regulate (1) binding to DNA and (2) binding to
hormones or ligands, which are small lipophilic molecules that modulate NR actions. The DNAbinding domains (DBD) of NRs consist of two zinc-fingers that enable the recognition of and
binding to specific DNA sequences (Freedman et al., 1988; Green et al., 1988). X-ray
crystallographic studies demonstrated that the DBDs are highly conserved and nearly
superimposable at the structural level (Luisi et al., 1991). The ligand-binding domains (LBD) of
NRs consist of 12 α-helices that bind ligands with high affinity and specificity (Bourguet et al.,
1995; Shiau et al., 1998; Wagner et al., 1995). The amino acid sequences of the LBD are less
conserved and intrinsically diverse in order to accommodate the recognition of specific ligands
with high fidelity while discriminating other ligands with similar biochemical properties in terms of
shape and size. Despite this diverse repertoire of selective ligand recognition, the LBDs also
exhibit highly similar three-dimensional structures, much like the DBD.
Ligands modulate NR activities by multiple molecular mechanisms. Classically, the
binding of ligands in the LBDs induces a conformational switch that exposes a C-terminal helix 12
(H12), which licenses the recruitment of co-activators to stimulate transcription (McKenna and
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O’Malley, 2002). In contrast, in the absence of ligands, NRs recruit co-repressors via their
unliganded C-terminal domains to actively repress transcription (Lazar, 2003). The ability of NRs
to promote transcriptional activation and repression through ligands is functionally important, as it
effectively generates a dynamic range in which NRs can regulate target gene expression.
Together, the DBDs and LBDs allow combinatorial and dynamic transcriptional control
unique to NRs: the DBDs dictate where to bind in the genome and thus what genes to regulate,
whereas the LBDs through their interactions with ligands and co-regulators determine both when
and the degree to which NRs can dial up and down target gene expression.

Molecular and Biological Function of Rev-erbα
Rev-erbα was cloned as an orphan NR in 1989 (Lazar et al., 1989, 1990). The name
“Rev-erbα” originated from the fact that its gene was transcribed from the reverse strand of
another nuclear receptor c-erbα (also known as thyroid receptor α; encoded by THRA), with
which Rev-erbα shares a 269 base pair segment of the bidirectionally transcribed region that is
exonic in both Rev-erbα and c-erbα genes. Rev-erbα is the founding member the NR superfamily
1 subgroup D (hence its gene name, NR1D1) that includes its highly related functional homolog
Rev-erbβ (encoded by NR1D2), both of which are also closely related to the ROR subfamily
(Dumas et al., 1994; Forman et al., 1994; Nuclear Receptors Nomenclature Committee et al.,
1999; Retnakaran et al., 1994). Rev-erbβ is also expressed in a circadian manner in the same
phase as Rev-erbα but with a less amplitude (Bugge et al., 2012). Consistent with this, mice
genetically lacking Rev-erbβ alone do not show much dysregulation of the clock and metabolism
unless Rev-erbα is also deleted, thus demonstrating that Rev-erbα and β likely serve redundant
functions to maintain the robustness of the clock (Bugge et al., 2012; Cho et al., 2012).
Among NRs, Rev-erbα and β are unique in that they lack the C-terminal H12, which is
required for the LDB-dependent recruitment of coactivators. Therefore, Rev-erbα and β both
serve as constitutive transcriptional repressors by recruiting co-repressors, NCoR1 (Nuclear
Receptor Co-Repressor; encoded by NCOR1) and the related SMRT/NCoR2 (Silencing Mediator
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of Retinoid and Thyroid Receptor; encoded by NCOR2) (Chen and Evans, 1995; Harding and
Lazar, 1995; Hörlein et al., 1995). However, Rev-erbα and β do not constitutively interact with
the co-repressors, and in fact, their interactions are regulated in multiple ways, such as by the
pattern of their genomic occupancy and by the presence of their ligand heme, the details of which
will be further discussed below.
Rev-erbα and β share highly homologous DBDs that recognize the same core hexameric
sequence (AGGTCA) with a 5’ A/T rich flank named RORE (ROR element), given that the ROR
subfamily members also bind to this sequence as monomers through their highly similar DBDs
(Giguere et al., 1995). Based on this shared biochemical property, Rev-erbs and RORs compete
for ROREs, which underlies the molecular basis by which Rev-erbs and RORs coordinate the
circadian expression of their target genes such as Bmal1. However, it is important to note that
when bound as monomers at ROREs, Rev-erbs do not recruit the co-repressors with high affinity
and thus likely represses transcription passively by replacing constitutively active RORs (Harding
and Lazar, 1995).
While Rev-erbα and β can bind to ROREs as monomers, they also bind as homodimers
to tandem direct repeats of the core sequence spaced by 2 base pairs with a 5’ A/T rich flank,
called RevDR2 (Harding and Lazar, 1995). Interestingly, binding to RevDR2 as homodimers
enables Rev-erbs to more strongly recruit the co-repressors, which then mediate active
transcriptional repression. Moreover, two monomeric Rev-erbα bound at widely spaced ROREs
can also recruit the co-repressors and actively repress transcription in the same manner as Reverbα bound at RevDR2 (Harding and Lazar, 1995; Zamir et al., 1997). These observations are
consistent with the biochemical demonstration that the optimal stoichiometry of their interaction is
one NCoR1 molecule to two Rev-erbα molecules (Zamir et al., 1997). In addition, heme bound to
the LBD of Rev-erbα stabilizes its interaction with NCoR1 and thus potentiates transcriptional
repression (Phelan et al., 2010; Yin et al., 2007). Recently, Rev-erbα has been shown to bind to
the genome in a DBD-independent manner by tethering to tissue-specific transcription factors to
regulate gene expression programs tailored to the function of a given tissue, alluding to an
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intriguing possibility that other genomic mechanisms of transcriptional regulation by Rev-erbα
may exist (Zhang et al., 2015).
For Rev-erbα and other NRs, active transcriptional repression with the co-repressors is
coordinated by a series of highly conserved biochemical interactions. Unliganded C-terminal
LBDs interact with short hydrophobic helices on NCoR1/2 named CoRNR boxes (co-repressor
nuclear receptor boxes) (Hu and Lazar, 1999). These CoRNR boxes are structurally similar to NR
boxes found on co-activators in that they all contain leucine-x-x-leucine-leucine motifs, which
enable binding to the LBD of NRs (Heery et al., 1997). The recruitment of the co-repressors
brings a large cohort of interacting proteins that also mediate transcriptional repression (Lazar,
2003). One of these proteins is histone deacetylase 3 (HDAC3). HDAC3 interacts with highly
conserved deacetylase activating domains of NCoR1 and SMRT, which are also necessary for
the catalytic activity of HDAC3 (Guenther et al., 2000, 2001; Watson et al., 2012). The genomic
recruitment of HDAC3 by the co-repressors thus leads to deacetylation of histones and potentially
other non-histone proteins, thereby repressing gene transcription (Alenghat et al., 2008; Feng et
al., 2011; Sun et al., 2012; You et al., 2013).
Rev-erbα coordinates circadian gene expression and physiology at large. In addition to
its regulation of Bmal1 expression, Rev-erbα and the co-repressor complexes co-localize
throughout the genome to control many tissue-specific gene expression programs, such as
thermogenic plasticity in the brown adipose tissue, dopaminergic signaling in the brain, and lipid
metabolism in the liver (Bugge et al., 2012; Chung et al., 2014; Gerhart-Hines et al., 2013; Jager
et al., 2014, 2016). While the classic hierarchical model of Rev-erbα recruiting the NCoRsHDAC3 complexes is well supported by numerous biochemical, genetic, and genomic studies, we
still lack complete molecular details of how Rev-erbα and its co-repressor complexes act at
enhancers and promoters to prime their activities and what kind of local biochemical changes in
their neighboring proteins drive transcriptional repression. Over the last few decades, the
realization that gene regulation is not only controlled by the sequence of the genome, but also by
other features of the genome such as histone modifications, DNA modifications, and three
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dimensional chromatin organization, led to the conception of “epigenome.” While the regulation of
histone modifications by NRs have been extensively studied and now well established, how NRs
and their co-regulators influence other aspects of the epigenome has not been fully explored and
thus warrants further investigation. In the next section, I will describe various components of the
epigenome and discuss new advances in our understanding with a specific focus on circadian
rhythms and NR biology when relevant.
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IV. Epigenomic Regulation of Transcription

How a gene can be turned on and off in the same cell and how its expression is restricted
to certain tissues without affecting any changes in the DNA sequence is a fundamental question
in biology that underscores the importance of epigenetic control in gene regulation. The term
“epigenetics” was coined by Conrad Waddington in 1942 to refer to heritable changes in
phenotype without changes in genotype. The term has which later gave rise to the term
“epigenomics” to describe genome-wide studies of various epigenetic states and functions (Allis
and Jenuwein, 2016). The major governing principle behind epigenetics is the reversibility of gene
expression, which is mediated by reversible biochemical reactions, such as covalent
modifications and non-covalent protein-protein interactions. In this chapter, I will specifically focus
two major aspects of the epigenomic regulation: (1) the role of chromatin modifications, and (2)
3D chromatin architecture and organization of the genome

Chromatin Modifications and Gene Regulation
The eukaryotic genome is composed of strands of DNA sequences, which are wrapped
around histone proteins round every 147 base pairs. This DNA-histone complex is called the
nucleosome, the smallest organizing unit of the larger genome-protein complexes collectively
called chromatin. Each nucleosome consists of two copies of each of the core histone proteins,
H2A, H2B, H3 and H4, although some histone variants may replace the core histones to generate
a diverse array of histone octamers with specialized functions (Luger et al., 1997; Sarma and
Reinberg, 2005)
The nucleosome can license various transcriptional activities through the modifications of
histone proteins. In particular, the tails of H3 and H4 subunits can be post-translationally
modified, which play critical roles in transcription. The observation that histones are methylated
and acetylated and the subsequent demonstration that mutations in histone tails perturbed gene
expression in the yeast led to the initial realization that histones and modifications on their tails
control transcription (Allfrey et al., 1964; Kayne et al., 1988).
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The first biochemical isolation and molecular cloning of the histone acetyltransferase
(HAT) p55 revealed that it was an orthologue of the yeast transcriptional coactivator Gcn5,
thereby directly linking histone acetylation to transcriptional activation (Brownell et al., 1996).
Soon after this discovery, the first histone deacetylase biochemically isolated and cloned turned
out to be an orthologue of the yeast transcriptional corepressor Rpd3 (Taunton et al., 1996).
These findings established the initial framework for the concept that histone acetylation and
deacetylation can turn genes on and off, respectively. In the following years, many other HATs
and HDACs were cloned and categorized based on their structural homologies, thereby ushering
in a transformative era dedicated to understanding how HATs and HDACs regulate gene
expression in opposing manners in a myriad of biological contexts (Haberland et al., 2009; Lee
and Workman, 2007).
In addition to histone acetylation, histone methylation constitutes another major class of
histone modifications. Similar to histone acetylation, methylation is catalyzed by a large group of
histone methyltransferases and erased by an equally large group of histone demethylases (Greer
and Shi, 2012). Basic residues on histones can undergo methylation, and depending on the
residue, can be mono-, di-, or tri-methylated, each with a discrete functional effect on
transcription. For instance, histone 3 lysine 27 tri-methylation (H3K27me3) catalyzed by PRC2
complex (Polycomb repressive complex 2) serves as a repressive marker. On the other hand,
histone 3 lysine 4 tri-methylation (H3K4me3) is classically associated with active promoters and
histone 3 lysine 4 mono-methylation (H3K4me1) is found predominantly at active enhancers
(Barski et al., 2007; Guenther et al., 2007; Heintzman et al., 2009).
These histone modifications have provided an unprecedented insight into gene regulation
on a genome-wide scale (Roadmap Epigenomics Consortium et al., 2015). For example, histone
3 lysine 27 acetylation (H3K27Ac) is widely used to define active enhancers (Rada-Iglesias et al.,
2011). Also, unique combinations of histone modifications have revealed novel transcriptional
signatures. During development, some genes gain bivalent histone markers consisting of active
H3K4me3 and repressive H3K27me3 on asymmetric nucleosomes at their promoters (Azuara et
al., 2006; Bernstein et al., 2006; Voigt et al., 2012). Due to the opposing effects of these histone
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markers, these genes become “poised,” such that they can be either activated or silenced at
different developmental stages.
The fact that histone modifications co-exist with one another in multiple and distinct
combinatorial ways provided the rationale for “the histone code hypothesis,” which states that
histone modifications and chromatin bound factors serve as a regulatory template on which the
genetic code is deciphered to determine the transcriptional output of a given gene (Jenuwein and
Allis, 2001; Strahl and Allis, 2000). In support of this hypothesis, H3K27me3 has been shown to
serve as a docking site for HP1 (heterochromatin Protein 1), which condenses nucleosomes to a
highly compact and repressive chromatin structure called heterochromatin (Bannister et al., 2001;
Lachner et al., 2001). Similarly, distinct combinations of transcription factors and surrounding
histone modifications can recruit specific ATP-dependent chromatin remodeling complexes to
loosen nucleosomes to a highly open and active chromatin structure called euchromatin by
mobilizing nucleosomes and further modifying local chromatin states (Ho and Crabtree, 2010).
Acetylation of histone lysine residues associated with euchromatic chromatin and active
transcription can further add functional complexity to the histone code repertoire because these
modifications can be recognized by a large family of transcriptional “readers” proteins containing
bromodomains (BRD) (Fujisawa and Filippakopoulos, 2017). BRD modules are found in a diverse
array of chromatin associated factors with various functions, such as transcriptional co-regulator,
histone-recognizing scaffolds for protein complex assembly, and histone modifiers with HAT,
ATP-dependent chromatin-remodeling activity, and methyltransferase activities (Filippakopoulos
et al., 2012; Fujisawa and Filippakopoulos, 2017). Furthermore, while BRD modules can
recognize acetylated histones, they can also bind to acetylation moieties on non-histone targets.
In support of this idea, although the structures of BRDs are highly conserved, the genomic
distributions of BRD-containing proteins can differ significantly, suggesting that additional
recognition elements are likely necessary to confer binding specificities to histones and nonhistone targets (Stonestrom et al., 2015).
In the recent years, the BRD proteins have been the focus of intense scientific
investigation due to the fact that the BRDs modules can be pharmacologically targeted in a
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specific manner. In particular, inhibiting the activity of BRD4 either by the BRD-selective JQ1
compound or by RNA interference has been shown to suppress tumor growth (Filippakopoulos et
al., 2010; Zuber et al., 2011). BRD4 binds acetylated histones commonly found at enhancers and
promoters and evicts nucleosomes through its intrinsic HAT activity. In addition, BRD4 also
promotes transcription by recruiting the cyclin-dependent kinase and elongation factor p-TEFb
(Devaiah et al., 2016; Dey et al., 2003; Kanno et al., 2014; Moon et al., 2005; Yang et al., 2005).
BRD4 can further interact with other transcriptional co-activators, including the Mediator complex,
to promote transcriptional activation. In support of this, pharmacological inhibition of BRD4 leads
to transcriptional inhibition preferentially at sites where both BRD4 and other co-activator bindings
are evicted (Bhagwat et al., 2016; Lovén et al., 2013; Roe et al., 2015). This example of dynamic
interplays among histone modifiers, histone modifications, and chromatin bound factors highlights
the elegant complexity of gene regulation.
These regulatory mechanisms are also critical for the transcriptional coordination of
circadian rhythms (Feng and Lazar, 2012). In contrast to Rev-erbs that bring HDAC3 to the
genome, RORs oppose their repressive action by bringing NCoA complexes (Nuclear receptor
Co-Activators) containing p300 and CBP with HAT activities (Jetten, 2007). Similarly, Clock has
an intrinsic HAT activity and can also complex with additional HATs, whose activities are opposed
by Cry-Per heterodimers that recruit the NuRD (Nucleosome Remodelling Deacetylase) complex
containing HDAC1/2 (Curtis et al., 2004; Doi et al., 2006; Duong et al., 2011; Naruse et al., 2004).
As a result, the anti-phasic rhythmic recruitment of HATs and HDACs to the genome by the core
clock transcription factors generates epigenomic rhythms that coordinate RNA Pol II recruitment
and nascent transcription (Fang et al., 2014; Feng et al., 2011; Koike et al., 2012; Menet et al.,
2012; Vollmers et al., 2012).
While this provides an important glimpse into the circadian regulation of the chromatin
structure, it is critical to recognize that our understanding of how other histone modifications and
chromatin bound factors contribute to the clock is far from complete. For instance, several studies
have demonstrated that some histone modifications are potentially correlative without causal
functions, and histone modifiers also have catalytic-independent and non-canonical functions
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(Dorighi et al., 2017; Emmett et al., 2017; Local et al., 2018; Poleshko et al., 2017; Rada-Iglesias,
2018; Sun et al., 2013). Therefore, whether histone modifications are correlative or causal, and
how chromatin modifiers regulate local chromatin environments as well as neighboring factors to
directly control transcription is an important direction of future research that warrants more
mechanistic elucidation.

3D Organization of the Genome
The observation that chromosomes occupy certain territories in the nucleus led to the first
recognition that the genome is organized in a non-random manner (Boveri, 1909; Cremer and
Cremer, 2010; Rabl, 1885). The development of various chromatin conformation capture (3C)
techniques, all of which are based on restriction enzyme-mediated digestion followed by
proximity-based ligation, has enabled us to probe into how the genome folds in three-dimensional
space and study how its structure controls genome function (Denker and de Laat, 2016;
Lieberman-aiden et al., 2009; de Wit and de Laat, 2012).
In the recent years, seminal studies conducted by independent labs have demonstrated
that the genome is partitioned into highly conserved units called topologically associating
domains (TAD) (Dixon et al., 2012; Nora et al., 2012; Sexton et al., 2012). These TADs are on
average one mega base pair long and conserved in different tissues, as well as in different
species, particularly at syntenic genomic regions where the linear order of genes are maintained
(Dixon et al., 2012). The boundaries of each TAD are anchored together by a pair of CTCF
(CCCTC-binding factor) proteins that, upon binding at both ends in a convergent orientation,
heterodimerize with each other to form a long-range chromatin loop, which is further stabilized by
the ring-like protein called Cohesin wrapping around the CTCF heterodimer (Dixon et al., 2012;
Phillips-Cremins et al., 2013; Rao et al., 2014). By spatially restraining a long region of
chromosome into a physically isolated domain, TADs serves as insulators to ensure that
enhancers and genes contained within the same TAD interact with one another, but not beyond
their TAD boundaries. Consistent with this idea, the disruption of TAD boundaries has been
shown to result the loss of functional insulation. For example, genetic variants that disrupt CTCF
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binding motifs drive ectopic enhancer-promoter rewiring between neighboring TADs, which
consequentially manifests as developmental limb malformations (Lupiáñez et al., 2015, 2016).
Similarly, hypermethylation at a CTCF binding motif that abrogates the binding of CTCF leads to
aberrant enhancer-promoter interactions that drive the expression of an oncogene in gliomas
(Flavahan et al., 2016).
In addition, TADs demarcate regions of euchromatin and heterochromatin (Liebermanaiden et al., 2009; Rao et al., 2014; Sexton et al., 2012). For instance, each TAD tends to contain
either all active or all repressed genes. Moreover, genes within the same TAD tend to share
similar patterns of expression (Nora et al., 2012). Furthermore, TADs containing active genes
spatially cluster together in a distinct higher order structure called Compartment A, whereas TADs
containing repressed genes separate out and cluster together in another distinct higher order
structure called Compartment B. Interestingly, Compartment B is also enriched with laminassociated domains (LAD), which have also been known to share similar functional
characteristics of Compartment B in that they contain repressed genes or no genes at all and are
decorated with repressive histone markers such as H3K27me3 (van Steensel and Belmont,
2017).
Recent studies have further redefined our current understanding of TADs. In cells in
which endogenous CTCF is acutely depleted, TAD boundaries and insulation between
neighboring TADs are disrupted, leading to both reduced and increased expression of genes
nearby CTCF due to ectopic loss and gain of enhancer targeting, respectively. Interestingly, the
organization of Compartment A and B remained largely intact and no appreciable spreading of
the repressive H3K27me3 mark was observed. Studies utilizing acute depletion of subunits of
Cohesin demonstrated similar findings in terms of the global disappearance of TAD structures,
the overall intact compartmentalization if not even enhanced, and disruption of gene expression
particularly nearby super enhancers known to be highly enriched for Cohesin binding (Rao et al.,
2014; Schwarzer et al., 2017). Therefore, while these studies further validate that TADs serves as
building blocks for the hierarchical organization of the genome, how these TADs become
compartmentalized into A/B and whether such compartmentalization causally controls
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transcription or occurs as a result of divergent transcriptional characteristics of TADs remain to be
determined.
Similarly to this enigma of how the genome folds and unfolds at the level of TADs and
compartments, we still lack a molecular understanding of how enhancer and promoter loops are
regulated (Bulger and Groudine, 1999; Chambeyron and Bickmore, 2004; Engel and Tanimoto,
2000; Kleinjan and van Heyningen, 2005; Ong and Corces, 2011; West and Fraser, 2005).
Generally, activator transcription factors bind enhancers and recruit other co-activators such as
the Mediator complex, which then interact with the transcription pre-initiation complex bound at
promoters, thus bridging enhancers and promoters into an activating chromatin loop (Malik and
Roeder, 2010; Soutourina, 2017). Of note, other studies have also reported that Cohesin
participates in forming enhancer-promoter loops, although not all enhancers may be bound by
Cohesin (Kagey et al., 2010; Rubin et al., 2017).
Despite this general understanding, very little is known about how enhancers that are
located far upstream or downstream of their target genes in the linear sequence can somehow
recognize their target promoters and physically loop to activate transcription. The insulator
function of TADs can only explain the fact that enhancers find their targets within the same TAD,
but this knowledge alone cannot sufficiently explain how enhancers do not necessarily interact
with the nearest promoters and rather selectively interact with their target promoters, sometimes
even by skipping several promoters. While this understanding is lacking, we have a new
opportunity to examine how enhancer loops are selectively formed within TADs. For instance, the
genome-wide 3C method Hi-C has enabled identification of thousands of enhancer-promoter
loops as well as the topology of their neighboring regions. By systemically interrogating the
molecular and topological characteristics of functional enhancer-promoter pairs, it is possible that
a consistent pattern may emerge to inform us about regulatory logics behind their interactions.

Circadian Regulation of 3D Genome Organization
Given that circadian rhythms are coordinated at the level of transcription, it is conceivable
that the genome organization may also be regulated in a circadian manner. Indeed, several
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studies have linked circadian transcription with circadian genome re-organization. For instance,
the DBP locus has been shown to undergo circadian inter-chromosomal interactions, although
the functional role of such in trans interactions in gene regulation remains controversial (AguilarArnal et al., 2013). Cohesin depletion in cells alters the local short-range topology of circadian
genes and cause aberrant expression of several circadian genes (Xu et al., 2016). A long-range
loop formed by CTCF undergoes circadian interactions with LADs (Zhao et al., 2015). However,
these studies have not addressed how enhancer-promoter loops are regulated in a circadian
manner. This question is particularly important in light of the fact that the core clock transcription
factors bind enhancers in a rhythmic manner to drive circadian gene transcription. Moreover, a
fundamental question as to how transcriptional repressors such as Rev-erbα control enhancerpromoter loops at a genome-wide level has long remained unanswered, although a few previous
studies have provided evidence that transcriptional repressors may inhibit enhancer-promoter
loops in a locus-specific manner (Chopra et al., 2012; Jing et al., 2008).
In the following chapter, we addressed these glaring questions in the circadian biology
field by applying Hi-C to mouse livers collected at different times of the day and characterizing the
circadian organization of the genome at the level of TADs and enhancer-promoter loops. We
found that interaction within TADs exhibit genome-wide organizational plasticity as part of normal
mammalian physiology. Our study has also provided a novel molecular insight into how Rev-erbα
opposes enhancer-promoter loops by modifying the epigenome and evicting chromatinassociated factors involved in transcription and looping (Kim et al., 2018; de Lima and Göndör,
2018).
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Chapter 2: REV-ERBα DYNAMICALLY MODULATES CHROMATIN LOOPING
TO CONTROL CIRCADIAN GENE TRANSCRIPTION

This chapter is adapted from
YH Kim*, SA Marhon*, Y Zhang, DJ Steger, KJ Won, MA Lazar, Rev-erbα dynamically modulates
chromatin looping to control circadian gene transcription, Science, 2018 (*equal contribution)
(Kim et al., 2018)

This work was highlighted in
Science and Genes & Development
(de Lima and Göndör, 2018; Weidemann et al., 2018)

Note: several key aspects of this work were reproduced and reported
by another group shortly after the publication of our work (Mermet et al., 2018)
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I. Abstract
Mammalian physiology exhibits 24-hour cyclicity due to circadian rhythms of gene
expression controlled by transcription factors that constitute molecular clocks. Core clock
transcription factors bind to the genome at enhancer sequences to regulate circadian gene
expression, but not all binding sites are equally functional. We found that in mice, circadian gene
expression in the liver is controlled by rhythmic chromatin interactions between enhancers and
promoters. Rev-erbα, a core repressive transcription factor of the clock, opposes functional loop
formation between Rev-erbα–regulated enhancers and circadian target gene promoters by
recruitment of the NCoR-HDAC3 co-repressor complex, histone deacetylation, and eviction of the
elongation factor BRD4 and the looping factor MED1. Thus, a repressive arm of the molecular
clock operates by rhythmically modulating chromatin loops to control circadian gene transcription.
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II. Results
Circadian rhythms of mammalian physiology are orchestrated by core clock TFs
functioning as activators or repressors in interlocking feedback loops that drive daily oscillations
of gene expression (Bass and Lazar, 2016; Takahashi, 2016). These TFs generate circadian
rhythms of histone modification at circadian enhancers (Fang et al., 2014; Feng et al., 2011;
Koike et al., 2012; Vollmers et al., 2012). Enhancer activities are mediated by looping to
promoters within insulated topologically associating domains (TADs) (Dixon et al., 2012; Nora et
al., 2012; Sexton et al., 2012). Previous studies with cultured cells have described circadian
regulation of higher-order chromatin organization (Zhao et al., 2015), long-range interchromosomal interactions (Aguilar-Arnal et al., 2013), and short-range chromatin loops (Xu et al.,
2016) at specific loci, but this has not been examined at a genome-wide level in native tissues
under normal physiology.
We performed in situ Hi-C (Lieberman-aiden et al., 2009; Rao et al., 2014) on C57BL/6J
mouse livers harvested 12 hours apart, at zeitgeber time 22 (ZT22, 5 AM) and ZT10 (5 PM) to
examine whether chromatin interactions change in a circadian manner. Hi-C identified megabasesize TADs whose boundaries were highly similar to those identified in mouse embryonic stem
cells (Fig. 2.S1A). This was expected because TADs are largely conserved among different
tissues (Dixon et al., 2012), and indeed the overall TAD organization was also highly similar
between ZT22 and ZT10 (Fig. 2.S1B).

Within each TAD we also observed sub-megabase

structures (sub-TADs) of different lengths (Fig. 2.S1C) that were flanked by CTCF and cohesin
(RAD21) and internally occupied by Mediator (MED1) (Fig. 2.S1D), as described previously
(Dowen et al., 2014; Phillips-Cremins et al., 2013; Rao et al., 2014; Siersbæk et al., 2017).
Globally, genomic occupancy of CTCF and cohesin at ZT10 versus ZT22 was very similar at subTAD boundaries (Fig. 2.S1E-F).
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Because TFs bind at enhancers to regulate genes confined within sub-TAD boundaries
(Dowen et al., 2014), we next searched for “intra-TAD” interactions occurring within sub-TADs. Of
6510 intra-TAD interactions, only 349 were ZT22-specific, whereas 527 were ZT10-specific
(Wilcoxon signed rank test, P < 0.001). For example, the circadian Npas2 gene exhibited
increased intra-TAD interactions at ZT22, including extensive looping between the transcriptional
start site and four non-coding regions (E1 to 4) (Fig. 2.1A). These non-coding regions mapped to
regions of divergent transcriptional activity characteristic of enhancer RNA (eRNA) that were
similarly regulated (Fig. 2.S2A). Intra-TAD interaction was also observed within the gene body,
as previously reported at actively transcribed genes (Grosso et al., 2012; Tan-Wong et al., 2012),
and this was enhanced at ZT22 as well (Fig. 2.1A).
Genome-wide, we identified hundreds of sub-TADs containing circadian genes whose
expression has been shown to peak between ZT21 and 24 (“ZT22 sub-TADs”) or between ZT9
and 12 (“ZT10 sub-TADs”) (Fang et al., 2014). The overall structure of these sub-TADs (Fig.
2.S2B) and the binding of CTCF and RAD21 at their boundaries (Fig. 2.S2C-D) changed very
little between ZT22 and ZT10 (Fig. 2.S2B-D). However, ZT22 and ZT10 sub-TADs exhibited
greater intra-TAD interactions corresponding to their transcriptional activities (Fig. 2.1B-C),
whereas non-circadian sub-TADs did not (Fig. 2.S3A). Similar conclusions were obtained when
the circadian windows were adjusted by 1 hour (Fig. 2.S3B-C). Interactions within gene bodies
were also circadian (Fig. 2.S3D-H).
The circadian Cry1 locus is located within a ZT22 sub-TAD, and Hi-C revealed an
interaction between the gene promoter and an intronic enhancer that was increased at ZT22 (Fig.
2.S4A-B), as best visualized by differential analysis of the data (Fig. 2.2A). The nuclear receptor
Rev-erbα, a repressive component of the mammalian clock whose expression peaks at ZT10 to
confer circadian expression of genes in the opposite phase (Fang et al., 2014; Preitner et al.,
2002; Zhang et al., 2015), binds at this intronic enhancer (Fig. 2.2A). The enhancer-promoter (E-
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P) loop identified in ZT22 Hi-C was confirmed by chromatin conformation capture (3C)
experiments (Fig. 2.2B). Tandem 3C and Rev-erbα chromatin immunoprecipitation (ChIP) at six
time points throughout the day revealed that this E-P loop was indeed circadian and in phase with
Cry1 mRNA expression, with a peak that was anti-phase to Rev-erbα binding (Fig. 2.2C). At
ZT10, both looping from the Rev-erbα site to the Cry1 promoter (Fig. 2.2D) and Cry1 gene
expression (Fig. 2.2E) were enhanced by knockout (KO) of Rev-erbα, which attenuated the
rhythmicity of these parameters over the course of 24 hours (Fig. 2.S4C). Reciprocally, ectopic
expression of Rev-erbα in liver was sufficient to reduce looping as well as mRNA expression at
ZT22 (Fig. 2.2F-G), consistent with an active role of Rev-erbα in opposing loop formation. We
next performed Hi-C on livers from mice genetically lacking Rev-erbα and harvested at ZT10,
which confirmed the enhanced E-P looping at the Cry1 locus (Fig. 2.S4D). Moreover, throughout
the genome, intra-TAD interactions that were normally favored at ZT22 were increased in the
genetic absence of Rev-erbα at ZT10 (Fig. 2.2H).
These findings suggested that the ability of Rev-erbα to oppose loop formation is a
critical feature at binding sites from which Rev-erbα actively represses transcription. To explore
the relationship between regulation of looping and functional repression, we identified Rev-erbα
binding sites that directly loop to promoters at ZT22 in the physiological absence of Rev-erbα. EP loops at Rev-erbα binding sites were defined as “engaged” when transcription of the gene body
was repressed at ZT10, or “passive” if not repressed (Fig. 2.3A-B). Engaged sites were highly
correlated with circadian eRNAs whose activity peaked around ZT18 to 24 (ZT18-24) antiphase
to Rev-erbα binding (Fig. 2.3C), demonstrating that engaged sites are direct links between
circadian eRNAs and genes repressed by Rev-erbα. De novo motif analysis at engaged sites
revealed enrichment of DNA motifs known to be bound by Rev-erbα directly (RORE and
RevDR2) (Harding and Lazar, 1995) or indirectly (HNF6) (Zhang et al., 2015) (Fig. 2.S5A),
whereas these motifs were not enriched at passive sites (Fig. 2.S5B). Although the number of
sub-TADs containing circadian genes from each phase was similar (Fig. 2.S5C), only engaged
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Rev-erbα sites were enriched in ZT18-24 circadian sub-TADs (Fig. 2.3D and 2.S5D).
Importantly, E-P interactions at engaged Rev-erbα binding sites were strengthened at ZT22
relative to ZT10 (Fig. 2.3E). Together, these findings show that the ability of Rev-erbα to oppose
E-P loops within sub-TADs is a likely determinant of active repression by Rev-erbα.
We next addressed the mechanism by which Rev-erbα binding controls circadian E-P
interactions. The repressive action of Rev-erbα is often mediated by recruitment of a corepressor
complex containing NCoR (nuclear receptor co-repressor) and HDAC3 (histone deacetylase 3)
(Yin and Lazar, 2005), leading to circadian histone deacetylation associated with repressed
enhancers (Feng et al., 2011). Indeed, recruitment of NCoR and HDAC3 was greater at engaged
Rev-erbα binding sites, with a modest average increase in Rev-erbα binding relative to passive
sites (Fig. 2.4A). Consistent with this finding, the previously demonstrated circadian acetylation
of histone H3 Lys
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(H3K27Ac) in mouse liver (Vollmers et al., 2012) was exaggerated at

engaged Rev-erbα binding sites, but was nearly absent at passive sites (Fig. 2.4B).

eRNA

transcription also demonstrated an enhanced circadian rhythm at engaged sites, which was
abrogated in livers lacking Rev-erbα (Fig. 2.4C); this finding shows that Rev-erbα was required
for the epigenomic rhythms that occurred selectively at engaged sites.
The transcriptional regulator BRD4 acts as a reader of acetylated histone (Dey et al.,
2003; Moon et al., 2005; Roe et al., 2015), and forms a functional transcriptional complex with the
well-established looping factor MED1 (Bhagwat et al., 2016; Jiang et al., 1998; Lovén et al., 2013;
Wu and Chiang, 2007). In agreement with the changes in H3K27Ac at engaged sites, BRD4
binding was greater at ZT22 than at ZT10, and this difference was attenuated in the genetic
absence of Rev-erbα (Fig. 2.4D). Similarly, MED1 was also evicted at engaged sites but not in
livers lacking Rev-erbα (Fig. 2.4E). The opposition of Rev-erbα to the circadian binding of BRD4
and MED1 was confirmed by ChIP-quantitative polymerase chain reaction (qPCR) in both the
genetic absence (Fig. 2.4F-G) and ectopic expression of Rev-erbα (Fig. 2.S6A-C). Focusing on
Rev-erbα binding sites where BRD4 is evicted at ZT10 (Fig. 2.S6D) revealed the concurrent
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eviction of MED1 (Fig. 2.S6E) and also independently predicted functional sites with circadian
eRNA transcription (Fig. 2.S6F). However, the binding of CTCF and RAD21 was low and not
circadian at Rev-erbα binding sites (Fig. 2.S6G-J).
Our findings (Fig 2.5) demonstrate genome-wide organizational plasticity at the level of
sub-TADs that occurs in a circadian manner as a component of normal mammalian physiology.
The mechanisms by which Rev-erbα functionally opposes E-P loop formation, leading to
circadian repression of gene transcription within sub-TADs, are likely applicable to other
transcriptional repressors whose function in controlling chromatin architecture is currently not as
well defined as for transcriptional activators.
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Figure 2. S1. Liver TADs and sub-TADs exhibit conserved boundaries and structure.
(A) Hi-C Heat maps of mouse embryonic stem cell (mESC), mouse liver at ZT22 and at ZT10
demonstrating conserved boundaries (dotted lines), represented as ICE-normalized Hi-C intensity.
(B) Mouse ESC and mouse liver TADs demonstrated conserved boundaries genome-wide.
(C) Size distribution of sub-TAD identified in ZT22 and ZT10 Hi-C, with average sizes of 315 kbp
and 344 kbp, respectively.
(D) Distributions of architectural factors CTCF (red), RAD21 (green), and MED1 (blue) within all
sub-TAD size-normalized to standard 5’ and 3’ boundaries.
(E) CTCF binding at ZT22 and ZT10 at the CTCF peaks identified within regions around sub-TAD
boundaries (± 2kbp boundary).
(F) RAD21 binding at ZT22 and ZT10 anchoring at the CTCF peaks identified in Fig. 2S1E.
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Figure 2. 1. Circadian sub-TADs undergo rhythmic intra-TAD compaction within stable
boundaries.
(A) Heat maps of ZT22 and ZT10 Hi-C demonstrating circadian intra-TAD interactions within
sub-TAD boundaries (dashed lines), as represented by Hi-C intensity normalized by iterative
correction and eigenvector decomposition (ICE). The transcriptional start site of the Npas2 gene
(TSS) forms rhythmic intra-TAD loops with upstream enhancers (E1-4) as well as with the gene
body, as illustrated by schematics below.
(B and C) ZT22 sub-TAD (B) and ZT10 sub-TAD (C) averaged differential changes in intra-TAD
interactions visualized as log2 ratio within size-normalized sub-TAD 5’ and 3’ boundaries (red=
higher interaction ratio at ZT22, blue=higher interaction ratio at ZT10).
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(A) Enhancers annotated by divergent eRNA transcription (dashed box) upstream of the Npas2
gene for Fig. 2.1A.
(B) Boundary overlap of ZT22 and ZT10 sub-TADs in ZT22 Hi-C and ZT10 Hi-C. The boundaries
for circadian sub-TADs are similarly identified in ZT22 Hi-C and ZT10 Hi-C.
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(left) and ZT10 (right) sub-TAD boundaries (± 2kbp boundary).
(D) RAD21 binding at ZT22 and ZT10 anchoring at the CTCF peaks identified in Fig. 2.S2C.
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Figure 2. S3. Intra-TAD interactions and gene body contacts exhibit circadian rhythms.
(A) Averaged differential changes in intra-TAD interactions of 1800 non-circadian sub-TADs
showed no appreciable difference.
(B and C) ZT20-23 (B) and ZT8-11 circadian sub-TADs (C) demonstrated averaged differential
changes consistent with intra-TAD interactions.
(D) Averaged differential changes in gene bodies for 2000 non-circadian genes.
(E and F) ZT22 circadian genes (E) and ZT10 circadian genes (F) exhibited changes consistent
with circadian intra-TAD interactions.
(G and H) ZT20-23 circadian genes (G) and ZT8-11 circadian genes (H) also exhibited
correspondingly consistent changes in gene bodies.
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Figure 2. 2. Rev-erbα causally opposes enhancer-promoter loop formation.
(A) Differential Hi-C analysis at the Cry 1 locus revealing ZT22-specific interactions,
represented as log2 ratio (ZT22 Hi-C/ZT10 Hi-C). ZT22-specific interactions (dashed circle)
occur between a region around the intronic Rev-erbα site (red) and the Cry1 TSS (blue). Global
run-on seq (GRO-seq) demonstrates circadian nascent transcription as well as the presence of
bidirectional eRNA at Rev-erbα site at ZT22.
(B) 3C validation of enhancer-promoter loop (E-P loop) identified at ZT22 between Rev-erbα
site (red) and TSS (blue) (n=5, mean ±SEM).
(C) Circadian plot demonstrating Cry1 E-P loop, mRNA expression, and Rev-erbα ChIP ±SEM
(n=4-5, P values shown for 3C and ChIP peaks compared to troughs, one-way ANOVA followed
by multiple comparisons correction with the Tukey method)
(D and E) E-P loop (D) and mRNA expression (E) of Cry1 at ZT22 (black), ZT10 (white), and
ZT10 Rev-erbα KO (red), represented as mean ±SEM (n=4, one-way ANOVA followed by
Dunnett’s multiple comparisons test).
(F and G) E-P loop (F) and mRNA expression (G) of Cry1 at ZT22 with control green
fluorescent protein (GFP) expression (black) versus Rev-erbα over-expression (blue) expressed
as mean ±SEM (n=5, two-tailed Student’s t-test).
(H) Same analysis as in Fig. 2.1B, but comparing ZT10 Rev-erbα KO (αKO) to ZT10 WT at
ZT22 sub-TADs (red= higher interaction ratio at ZT10 αKO, blue=higher interaction ratio at
ZT10 WT).
* P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001
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Figure 2. S4. Regulation of enhancer-promoter looping at the Cry1 locus by Rev-erbα.
(A and B) ZT22 (A) and ZT10 (B) Hi-C heat maps at the Cry1 locus, represented as ICEnormalized Hi-C intensity. Stronger interactions were detected around Rev-erbα-regulated site
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mRNA expression (red dashed line).
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Figure 2. 3. Rev-erbα attenuates enhancer-promoter looping at functional binding sites.
(A) Rev-erbα sites at E-P loops were classified as “engaged” when looped to genes whose
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Figure 2. 4. Functional Rev-erbα binding evicts BRD4 and MED1 from sites of looping.
(A) Greater recruitment of NCoR1 and HDAC3 at engaged Rev-erbα sites associated with a slight
average increase in Rev-erbα binding (Mann-Whitney tests).
(B) Circadian deacetylation of H3K27Ac at circadian time 21 (CT21, black) and CT9 (dashed) at
engaged vs. passive sites. Dataset from (Vollmers et al., 2012).
(C) Circadian eRNA transcription between ZT22 (black) and ZT10 (dashed), with increased
transcription at ZT10 in αKO (red) at engaged sites. Dataset from (Fang et al., 2014).
(D and E) Circadian eviction of BRD4 (D) and MED1 (E) between ZT22 and ZT10, with enhanced
binding at ZT10 in αKO at engaged sites (Dunn’s multiple comparisons tests after one-way
ANOVA/Friedman test).
(F and G) ChIP-qPCR validation of BRD4 (F) and MED1 (G) eviction at ZT10 and enhanced
binding at ZT10 in αKO at engaged sites (Ins as a negative control, n=3-4, two-way ANOVA
followed by Dunnett’s multiple comparisons test).
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Figure 2. S6. Rev-erbα opposes recruitment of BRD4 and MED1, but not CTCF and
RAD21.
(A-C) FLAG-Rev-erbα (A), BRD4 (B), and MED1 (C) ChIP-qPCR at engaged Rev-erbα sites
upon ectopic expression of Rev-erbα at ZT22.
(D) Rev-erbα sites sub-grouped into “BRD4-evicted” sites based on BRD4 binding fold
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(E) BRD4-evicted Rev-erbα sites exhibit concurrent eviction of MED1 occupancy (MannWhitney tests).
(F) BRD4-evicted Rev-erbα sites independently predict functional enhancers with circadian
eRNA transcription.
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(G) CTCF binding at engaged and passive Rev-erbα sites at ZT22 versus ZT10.
(H) Average profile of CTCF at CTCT-RAD21 co-occupied sites (black line), engaged (red), and
passive (blue) demonstrated unappreciable binding of CTCF at Rev-erbα sites.
(I) RAD21 binding at engaged and passive Rev-erbα sites at ZT22 versus ZT10. (J) Average
profiled of RAD21 at CTCT-RAD21 co-occupied sites (black line), engaged (red), and passive
(blue) also demonstrated unappreciable binding of RAD21 at Rev-erbα sites.
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CHAPTER 3: IDENTIFICATION AND CHARACTERIZATION OF A NOVEL
CIRCADIAN ETS FACTOR

Parts of this chapter are adapted from my F30 application

Most of the experiments here were proposed and performed by myself. Chunjie Jiang performed
RNA-seq analyses and helped with other aspects of bioinformatics analysis. Yumiao Han of the
Garcia lab at Penn provided critical help with mass spectrometry analysis.
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I. Abstract
The circadian clock is an evolutionarily conserved biological mechanism by which
organisms anticipate and adapt to daily environmental changes. This internal clock orchestrates
all-encompassing aspects of physiological homeostasis, such as sleep, body temperature, and
metabolism. The circadian clock is established by a series of negative feedback loops among
clock transcription factors, which ultimately result in 24-hour periodicity. Disruptions in the clock
machineries due to genetic or environmental causes lead to devastating health consequences,
including neuropsychiatric disorders and metabolic derangements. As such, this warrants a
deeper understanding of how circadian rhythms are regulated or dysregulated in health and
disease, respectively.
To determine how clock transcription factors coordinate gene transcriptions in a circadian
manner genome-wide, our lab has recently identified small non-coding enhancer RNAs (eRNA)
over a 24-hour period in the mouse liver. These eRNAs serve as an excellent functional marker
for enhancer activities. We uncovered several groups of “circadian eRNAs” whose transcription
oscillates in a circadian manner. Furthermore, de novo motif analysis revealed that each group of
eRNAs peaking at a given phase was enriched with the distinct consensus binding motif of the
TFs that drive their circadian expression, and most of these phase-specific motifs were of known
circadian regulators. Interestingly, one motif peaking at ZT0-3 was an E-Twenty-six (ETS) motif
recognized by the ETS TF family. However, there is no ETS factor known to behave in a
circadian manner.
In an unbiased proteomics approach, we have identified and determined for the first time
that GA-binding protein α (GABPα) binds to the loci of those circadian eRNAs with an ETS motif.
Moreover, our preliminary data demonstrated that despite the constitutive genomic occupancy of
GABPα, nascent transcription at GABPα peaks occurred in a circadian manner genome-wide.
Furthermore, liver-specific knockout of GABPα resulted in massive enlargement of the liver with
mitochondrial dysfunction and severe metabolic derangements. Transcriptomic studies revealed
that the knockout liver reveals patterns of gene expression patterns consistent with senescence.
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We identified TYMP encoding thymidine phosphorylase as a putative causal gene that was
directly controlled by GABPα and expressed in a circadian manner. In support of this finding,
human mutations in this gene lead to various mitochondrial dysfunction, which has been known to
drive senescence. Furthermore, we validated gene expression changes that support the
senescence pathology. Interestingly, we observed that not only many pro-inflammatory
senescence-associated secretory phenotype genes were up-regulated in the genetic absence of
GABPα, but they also gained a circadian rhythm of expression. This suggested that the loss of
GABPα resulted in the gain of a pathological rhythm driving the temporal progression of
senescence.
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II. Introduction
Circadian rhythms are biological oscillations that have evolved in anticipation of and
adaptation to environmental fluctuations occurring every 24 hours. The rhythmicity of these timespecific and recurrent fluctuations is intrinsically orchestrated by negative feedback loops among
several clock transcription factors (e.g. Bmal1, Clock, Cry, Per, Rev-erb and ROR), which
ultimately result in 24-hour periodicity (Fang et al., 2014; Koike et al., 2012). In the mammalian
system, the central circadian clock resides in the suprachiasmatic nucleus of the hypothalamus,
which integrates light input to synchronize the circadian rhythms of peripheral target tissues via
neurohormonal feedback loops (Bell-Pedersen et al., 2005; Gamble et al., 2014; Hastings et al.,
2007). Peripheral clocks, while regulated by both the internal clock and the central clock, can also
be independently entrained by organ-specific functional cues (e.g. food intake for the liver) in
order to properly mount an adaptive response (Lamia et al., 2009; Stokkan et al., 2001). Taken
together, the circadian clock serves as a critical physiological rheostat to modulate daily
anticipatory changes with stimulus-dependent adaptive changes.
Consistent with this pivotal role of circadian rhythms in homeostasis, environmental and
genetic disruptions of the circadian clock can result in profound human diseases, such as
metabolic derangements and neuropsychiatric disorders (Eckel-Mahan and Sassone-Corsi, 2013;
Feng and Lazar, 2012; Mansour et al., 2006; Wulff et al., 2010). In particular, circadian
misalignment has been highly implicated with metabolic diseases in epidemiological studies of
shift and night workers (Biggi et al., 2008; Fonken et al., 2010; Pietroiusti et al., 2010; Scheer et
al., 2009; Wang et al., 2011). These studies suggest that shift workers are more likely to suffer
from higher BMI and increased incidence of cardiovascular and metabolic comorbidities
compared to daytime workers. Moreover, another study has shown that visceral fat adipocytes of
obese patients show altered clock gene expression compared to lean controls (Yore et al., 2014).
Despite this clear implication of circadian misalignment in metabolic diseases, we still lack a
mechanistic and molecular understanding of how such pathophysiologic processes are initiated
and perpetuated.
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In order to better understand how various clock transcription factors coordinate gene
expression to orchestrate circadian hepatic metabolism, our lab performed Global Run-On
sequencing (GRO-seq) with mouse livers collected over a 24-hr period (Fang et al., 2014). GROseq is a powerful tool that measures dynamic nascent transcriptions genome-wide, instead of
steady state mRNAs (Core et al., 2008). More importantly, GRO-seq can identify enhancer RNAs
(eRNA), short (~50-2000 bp) non-coding RNAs transcribed at enhancers (Kim et al., 2010). While
the exact molecular function of eRNAs remains to be determined, eRNAs have been widely used
not only to denote putative enhancers but also as a robust functional marker for enhancer activity
(Lam et al., 2014). Using this unbiased genome-wide approach, we have identified “circadian
eRNAs” whose transcriptions oscillate in a circadian manner, and further categorized them into
phase-specific groups based on the peaks of their expression. Next, we performed de novo motif
analyses to show that each phase-specific group of circadian eRNAs was enriched with the
distinct consensus binding motif of the TFs that drive their expression. As expected, many of
these phase-specific motifs were those of known circadian TF (e.g. E-box for Bmal1,
RORE/RevDR2 for ROR and Rev-erb, and D- box for E4BP4/Nfil3). Unexpectedly, circadian
eRNAs peaking at ZT0-3 showed the enrichment of ETS motifs, which are recognized by the ETS
transcription factor family (Sharrocks, 2001). However, to date, there is no ETS factor known to
behave in a circadian manner. This intriguing observation motivated us to search for this novel
circadian ETS factor and characterize its physiological role in coordinating circadian hepatic
metabolism.
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II. Results
In order to identify this unknown ETS factor, we devised an unbiased proteomics strategy
called Oligo-Pull down followed by Mass Spectrometry (OP-MS) (Mittler et al., 2009). The major
advantage of OP-MS over other candidate-driven approaches is that it pulls down the most
abundantly expressed and actively DNA binding ETS factors. In this method, short biotinylated
oligonucleotides containing either an ETS motif or the reverse sequence (revETS) as a negative
control are incubated with mouse liver nuclear extracts and isolated with streptavidin-coated
beads (Fig. 3.1A). Using highly sensitive and high-throughput MS, we identified the GABPα/β
complex that was selectively enriched in the ETS oligonucleotides (Fig. 3.1B). Next, ChIP-qPCR
demonstrated that both GABPα and GABP β 1/2 are bound at enhancers with ETS motifs and
circadian eRNAs transcription (eRNA_ETS1-3) (Fig. 3.1C). This suggests that the
GABPα/β complex is likely the ETS factor that regulates the circadian expression of eRNAs at
ZT0-3. Surprisingly, however, their binding was not circadian, suggesting that their activity was.
GABPα and β form heterodimer and heterotetramer complexes via a series of ankyrin
repeats on the β subunit (Batchelor, 1998). The α subunit contains a DNA binding domain that is
highly conserved in the ETS family, whereas the β subunit contains a transactivation domain that
recruits and interacts with transcriptional co-activators (Karim et al., 1990; Vercauteren et al.,
2008). The biological roles of GABPα/β are diverse, tissue-specific, and particularly critical for
development, as GABPα KO is pre-implantation lethal (Ristevski et al., 2004). GABPα and β have
been implicated in myeloid lineage development, cell cycle regulation, and mitochondrial
biogenesis (Bush et al., 2003; Resendes and Rosmarin, 2006; Scarpulla, 2008; Vercauteren et
al., 2008; Yang et al., 2007, 2014). Unlike GABPα that is encoded by one gene GABPA with two
5’ transcript variants that encode the same protein, the expression of GABPβ is considerably
more complex; there are GABPB1 and GABPB2, each producing multiple splicing isoforms
(Rosmarin, 2004; Scarpulla, 2008). As GABPα is the only ETS factor that can recruit GABPβs
and is essential for the genomic binding of both subunits, we focused on GABPα to further
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investigate the circadian transcriptional regulation by the GABPα/β complex.
First, we performed ChIP-seq to define where GABPα binds in the genome. Its liver
cistrome showed a relatively high distribution at TSS, but the majority of its peaks were located at
putative cis-regulatory elements in intergenic and intragenic regions. (Fig. 3.1D). Next, to
determine whether the GABPα peaks co-localizes with circadian eRNAs from ZT0-3 genomewide, we generated a circadian plot using the top 3000 non-promoter peaks (Fig. 3.1D). In the
circadian plot, the bars represent the fraction of eRNAs expressed at given ZTs that has ETS
motifs, whereas the line plot indicates the fraction of the GABPα cistrome that overlaps with
eRNA expressed at given ZTs. Not only did eRNAs show a circadian enrichment of ETS motifs at
ZT0-3 as previously reported, but their overlap with the GABPα cistrome also followed the same
circadian pattern (R=0.8768), with the highest overlap occurring in the expected ETS phase at
ZT0-3.
We next sought to identify high confidence GABPα peaks by eliminating potential offtargets of the antibodies used in the previous experiment. To do so, we obtained floxed GABPA
mice, to which we administered hepatotropic adeno-associated virus 8 (AAV8) harboring the liverspecific thyroxine-binding globulin (TBG) promoter driving Cre recombinase expression to
specifically knock out GABPα in the liver. First, we confirmed that GABPα was efficiently knocked
out using this system as early as 7 days post injection (Fig. 3.2A). Next, we performed ChIP-seq
for GABPα and GABPβ1/2 in floxed mice injected with AAV8-TBG-GFP virus as a control versus
those injected with AAV8-TBG-Cre virus as a liver-specific knockout (L-KO). We then
bioinformatically called high confidence GABPα peaks identified in the control liver that
disappeared in GABPα L-KO (Fig. 3.2B). Consistent with the previous data, the binding of
GABPα was not circadian. More importantly, at these high confidence GABPα peaks, the binding
of GABPβ1/2 mirrored that of GABPα, thus demonstrating that GABPα is indeed essential for the
genomic recruitment of GABPβ1/2 (Fig. 3.2C).
To test our hypothesis that GABPα is the circadian ETS factor, we next addressed if
these high confidence GABPα peaks exhibited a circadian rhythm of nascent transcription by
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performing an average profile analysis with the previously generated GRO-seq data of wild type
mouse livers collected at ZT1 and ZT13 (Fang et al., 2014). Consistent with our hypothesis that
GABPα stimulates nascent transcription in a circadian manner with a peak around ZT0-3,
nascent transcription was also circadian at these peaks, the highest at ZT1 and the lowest at
ZT13, which was not observed at the previously defined non-oscillating eRNA sites used as a
negative control (Fig. 3.2D-F). Taken together, this demonstrates that despite the constitutive
genomic occupancy, GABPα is associated with circadian nascent transcription genome-wide in
the ETS phase ZT0-3, further supporting that GABPα is likely the circadian ETS factor that
functions through its circadian transcriptional activity.
Next, we investigated the physiological function of GABPα in the liver. Interestingly,
mouse livers lacking GABPα became pale and massively enlarged compared to the control (Fig.
3.3A). H&E staining revealed that hepatocytes were disorganized and polymorphic with an overall
increase in size (Fig. 3.3B). This increase in cell size became more appreciable in E-cadherin
immunohistochemistry, thus suggested that the liver enlargement seen in L-KO was likely due to
cellular swelling (Fig. 3.3C). The liver is highly packed with mitochondria, which are responsible
for its brown appearance. Given the known role of GABPα in regulating mitochondrial functions,
we wondered if the pale color seen in the KO livers was caused by defects in mitochondria.
Indeed, electron microscopy (EM) studies revealed global dysregulation of mitochondrial shape
and number in hepatocytes lacking GABPα, particularly notable for extensive mitophagy (Fig.
3.3D). Consistent with these observed mitochondrial defects, L-KO mice also showed a broad
range of metabolic derangements, including reduced amounts of glycogen, cholesterol, and
triglyceride in the liver and increased glucose tolerance (Fig. 3.4A-B). Together, these data
demonstrate that GABPα is a critical regulator of hepatic physiology through its transcriptional
regulation of mitochondrial functions and integrity.
To better understand how GABPα L-KO progressively leads to these profound changes
in an unbiased way, we performed RNA-seq experiments with control and L-KO livers collected at
ZT1 on day 7, 10 and 14 post virus injection. Transcriptomic analyses identified hundreds of

50

differentially expressed genes from each group, most of which shared similar patterns of
differential gene expression in other groups as well (Fig. 3.5A). On day 7, pathways related to
ribosomal biogenesis were down-regulated whereas pathways related to mitosis were upregulated. However, by day 14, pathways related to various metabolic processes were downregulated whereas pathways related to inflammation were up-regulated (Fig. 3.5B-D). Comparing
the overlap among differentially up- and down-regulated genes demonstrated that downregulated genes were more commonly shared, implying that down-regulated genes may be the
underlying cause of changes and that up-regulated genes are likely secondarily induced in a
temporally progressive manner upon L-KO (Fig. 3.5E-F).
To identify a causal driver of the liver phenotype, we have undertaken a candidate
approach and examined known functions of top most down-regulated genes. From this search,
we identified the TYMP gene encoding thymidine phosphorylase (TP) that was consistently downregulated on day 7, 10 and 14 in L-KO RNA-seq (Fig. 3.6A). In addition, ChIP-seq data revealed
high confidence GABPα and GABPβ1/2 peaks in the intragenic region, thus suggesting this gene
is a direct target of GABPα (Fig. 3.6A). Consistent with the circadian control of this gene by
GABPα, this gene was circadianly expressed with a peak at ZT0-3 (Fig. 3.6B). More importantly,
both its expression and circadian rhythmicity were abolished in L-KO, thus demonstrating this
gene is circadianly and directly regulated by GABPα (Fig. 3.6B).
TP is an enzyme that catalyzes the first step of thymidine (dThd) and deoxyuridine (dUrd)
catabolism. Human mutations in the TYMP gene manifest as a genetic disorder called
Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE), which is inherited in an
autosomal recessive pattern (Nishino et al., 1999). Mechanistically, the genetic absence of TP
leads to the systemic and pathologic accumulation of dThD and dUrD, which consequently leads
to an imbalance in the mitochondrial pool of dNTPs (Martí et al., 2003). Such imbalance critically
interferes with the replication of mitochondrial DNA, thereby resulting in severe mitochondrial
dysfunction (González-Vioque et al., 2011; López et al., 2009).
This functional role of TP is consistent with our finding that GABPα L-KO exhibited
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mitochondrial defects, as corroborated by the EM and metabolic studies. Mitochondrial
dysfunction can result in a cohort of cellular defects, including increased oxidative stresses and
radical oxygen species (ROS). An unchecked ROS level has been shown to cause extensive
DNA damages, which can provoke cellular senescence. Senescent cells are characteristically
different from non-dividing cells in that senescent cells often are morphologically enlarged,
express tumor suppressors and cell cycle inhibitors, and implement pro-inflammatory responses
known as senescence-associated secretory phenotype (SASP) (Muñoz-Espín and Serrano,
2014).
Interestingly, these characteristic changes are remarkably similar to the molecular
changes observed in GABPα L-KO hepatocytes in many aspects. First, hepatocytes lacking
GABPα assumed an enlarged morphology classically seen in senescent cells. Also, the previous
transcriptomic analyses revealed gene expression patterns consistent with progressively
worsening senescence. In the early phase of L-KO, cell cycle and mitosis-related pathways are
differentially up-regulated. In addition, DNA damage has been shown to cause replication stress,
which can down-regulate many ribosomal genes, as observed in the RNA-seq of day 7 L-KO. In
support of this, defects in ribosomal biogenesis has also been shown to causally drive
senescence (Nishimura et al., 2015). Finally, in support of the implementation of SASP, many
inflammatory genes were significantly up-regulated in the RNA-seq of day 14 L-KO. Furthermore,
we corroborated these pathway analyses by identifying individual genes involved in all of these
pathways, some of which are previously associated with senescence (Fig. 3.7A).
Finally, we validated senescent-associated changes in gene expression by qPCR. We
specifically focused on SASP genes as they represent the terminal stage of senescence.
Consistent with the RNA-seq analyses, many of these genes were up-regulated in a cohort of
livers with after 14 days post virus injection (Fig. 3.7B). Intriguingly, many of these genes also
gained circadian rhythms in the genetic absence of GABPα with peaks around ZT0-3, the time
point expected to be controlled by GABPα and also when TYMP expression is normally peaking
in the livers. This potentially suggests that senescence gene expression program is induced in a
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circadian manner in the absence of GABPα and TP, which are likely required to maintain
mitochondrial functions and protect against ROS. Together, these studies demonstrate that
GABPα maintains hepatic physiology through its transcriptional regulation of mitochondrial
genes, such as TYMP, and if functionally compromised, can give rise to senescence pathology
(Fig. 3.8A).
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Figure 3. 1. Identification of GABPα as an ETS factor at circadian eRNAs from ZT0-3
(A) Schematics of OP-MS method
(B) Volcano plot summarizing the identification of GABPα/β complex bound specifically to
the oligonucleotide with an ETS motif (n=3)
(C) ChIP-qPCR validation of GABPα and GABPβ1/2 binding at known ZT0-3 circadian
eRNA sites with ETS motifs, INS used as negative control site. (n=3)
(D) Genomic distribution of GABPα cistrome in wild-type liver
(E) Circadian plot demonstrating a circadian enrichment of ETS motifs at ZT0-3 and a high
degree of overlap between top 3000 GABPα non-promoter peaks with ZT0-3 circadian
enhancers
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Figure 3. 2. High confidence GABPα peaks show a circadian rhythm of nascent
transcription
(A) GAPBα is efficiently knocked out by AAV8-TBG-Cre virus injection as early as day 7 post
injection. AAV8-TBG-GFP virus is used as a negative control
(B) Average profile demonstrating high confidence GABPα peaks that are depleted in GABPα
L-KO. No change in binding was observed between ZT1 and ZT13. Mouse livers after 14 days
post virus injection were used for ChIP-seq
(C) Average profile demonstrating that, at high confidence GABPα peaks, the binding of
GABPβ1/2 is abrogated in the absence of GABPα. No change in binding was observed
between ZT1 and ZT13, similar to the binding pattern of GABPα. Mouse livers after 14 days
post virus injection were used for ChIP-seq
(D-F) Average profile of GRO-seq at top 3000 high confidence GABPα intergenic peaks (D), at
top 3000 high confidence GABPα promoter peaks (E), previously defined non-oscillating eRNA
sites (F). Circadian nascent transcription peaking at ZT1 was observed at both high confidence
GABPα intergenic and promoter peaks, but not at non-oscillating eRNA sites. GRO-seq data
from (Fang et al, 2014)
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Figure 3. 3. GABPα L-KO livers show morphologic changes and mitochondrial defects
after 14 days post virus injection

(A) Gross pathology revealing that GABPα L-KO causes massive enlargement of the liver
(B) H&E staining revealing that hepatocytes lacking GABPα are polymorphic and disorganized
with an overall increase in size.
(C) Immunohistochemistry of E-cadherin revealing that cell size is increased in GABPα L-KO
(D) Electron microscopy images revealing various dysmorphic changes in mitochondria,
particularly notable for extensive mitophagy.
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Figure 3. 5. RNA-seq analyses identified differentially expressed in GABPα L-KO after 7,
10, and 14 days post virus injection.
(A) Heat maps demonstrating differentially expressed genes between GFP control and GABPα
L-KO after 7, 10, and 14 days post virus injection. The livers were harvested at ZT1
(B-D) Gene ontology analyses of differentially down- and up-regulated genes on day 7 (B), day
10 (C), and day 14 (D) post virus injection
(E-F) Overlap analyses of differentially down-regulated (E) and up-regulated genes (EF).
Differentially down-regulated genes show a greater degree of overlap
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Figure 3. 6. TYMP is a direct GABPα target gene that shows circadian expression
(A) Genome-browser track showing a high confidence GABPα peak in the intragenic region of
the TYMP gene, as well as RNA-seq demonstrating that TYMP expression is abolished upon
GABPα L-KO.
(B) qPCR validation demonstrating that TYMP expression is circadian with a peak at ZT1. Both
the expression and circadian rhythmicity of the TYMP gene is abolished in GABPα L-KO.
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Figure 3. 7. Senescence-associated genes are up-regulated, and SASP genes gain
circadian expression peaking in the ETS phase in GABPα L-KO after 14 days post virus
injection
(A) Genome browser tracks demonstrating differential expression of several senescenceassociated genes in different pathways, such as up-regulation of cell cycle inhibitors genes (p51
and p21), down-regulation of DNA damage/repair genes (telomerase and Nudt1), and upregulation of SASP/pro-inflammatory genes (IL1a, Cxcl1, and Ccl2).
(B) qPCR validation of SASP genes that are up-regulated in GABPα L-KO. These genes gain
circadian expression peaking in the ETS phase, potentially due to the lack of TYMP expression
and other mitochondrial functions that are required to combat ROS and DNA damage in a
circadian manner, thereby leading to circadian induction of senescence gene program.
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(A) A potential model describing the temporal progression of gene expression and phenotypic
changes that lead to pathologic senescence observed in GABPα L-KO.
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CHAPTER 4: DISCUSSIONS AND FUTURE DIRECTIONS
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I. Summary
In my thesis, I sought to address the mechanisms by which circadian rhythms are
transcriptionally regulated from two major angles: (1) how the core clock transcription factor Reverbα controls enhancer-promoter looping in a circadian manner, and (2) how the transcription
factor GABPα potentially serves as a novel circadian ETS factor to maintain hepatic physiology.
In Chapter 2, we examined the interplay between the 3D genome organization and the
core clock transcription factors by applying Hi-C to mouse livers. This genome-wide tool identified
stable TAD structures, within which enhancer-promoter interactions occurred in a circadian
manner. Furthermore, we demonstrated that Rev-erbα as a transcriptional repressors opposed
enhancer-promoter loops. Mechanistically, such opposition of looping was mediated by the
eviction of BRD4 and MED1 upon Rev-erbα binding, which induced local histone deacetylation by
recruiting the NCoR-HDAC3 complex. Together, this study revealed genome-wide 3D
organizational plasticity that occurs in normal mammalian physiology and also a novel role of
transcriptional repressors in opposing enhancer-promoter loops to repress gene transcription.
In Chapter 3, we identified GABPα as an ETS transcription factor with potential circadian
transcriptional activity. Genome-wide analyses revealed a high degree over overlap between
GABPα cistrome and ZT0-3 circadian enhancers as well as circadian nascent transcription
occurring at GABPα cistrome. Mouse livers lacking GABPα exhibited a cohort of pathologies,
including liver enlargement, cellular swelling, mitochondrial defects and metabolic derangements.
We identified TYPM as a direct GABPα target gene that may be primarily responsible for the
observed mitochondrial defects, which may drive cellular senescence. Indeed, both phenotypic
and gene expression changes observed in GABPα L-KO were consistent with known features of
cellular senescence. Interestingly, SASP genes were expressed in a circadian manner in GABPα
L-KO, suggesting that the loss of a normal rhythm resulted in the gain of a pathologic rhythm.
In the next sections, I will discuss the implications of our findings in a broader scientific
context and discuss future plans for both projects going forward.
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II. Regulation of Enhancer Promoter Looping by Other Factors
Our work has demonstrated that circadian enhancer promoter looping controls circadian
gene transcription. Shortly after the publication of our work, another group has reproduced our
finding and independently demonstrated that the Cry 1 promoter circadianly interacts with the
intronic enhancer by the one-to-all 4C method (Mermet et al., 2018). Moreover, they genetically
deleted the intronic enhancer, which compromised rhythmic enhancer-promoter contacts at the
locus and resulted in shortening of circadian locomotor activity rhythms in mice. Together, these
findings further corroborate the notion that circadian enhancers dynamically loop to promoters to
drive gene transcription, although our understanding of how this is mediated at the molecular
level is relatively rudimentary.
Here, we focused specifically on Rev-erbα and examined its role in opposing enhancer
promoter loops by both loss-of-function and gain-of-function experiments. However, the
mechanism of transcriptional repression by Rev-erbα is considerably more complex, as described
in the introduction. For instance, as monomers bound at ROREs, Rev-erbα does not strongly
recruit the NCoR-HDAC3 complex and thus serves as a passive repressor by replacing RORs.
Given that our proposed model implicates HDAC3-dependent histone deacetylation as a critical
component of the molecular mechanism, this finding may seem inconsistent. However, it is
important to note that replacing RORs will likely result in molecular consequences very similar to
active transcriptional repression mediated by the NCoR-HDAC3. Indeed, RORs recruit both HATs
and the Mediator complex to the genome (Atkins et al., 1999). Therefore, if Rev-erbα replaces
RORs at ROREs, the genomic recruitment of BRD4 and MED1 will also likely be abrogated and
result in disruption of looping.
Similarly, the mechanism by which the NCoR1-HDAC3 complex mediates transcriptional
repression and opposes enhancer-promoter loops needs further molecular elucidation. The most
logical next steps are to examine changes in enhancer promoter loops in the genetic absence of
these factors or by pharmacological inhibition of HDAC3 or BRD4. However, interpretation of
such data may not be linear as expected due to several experimental caveats. For instance, while
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HDAC3 is considered the business arm of the complex, NCoRs interact with a large cohort of
additional regulatory partners, such as Gps2, Tbl1x, and Tbl1xr1 (Lazar, 2003). Moreover,
HDAC3 has both non-catalytic functions and non-canonical functions. Consistent with this idea,
knocking out NCoR1, NCoR2 and HDAC3 in the liver individually resulted in similar phenotypes
but did not completely phenocopy one another (Feng et al., 2011; Sun et al., 2013). Therefore, a
single locus experiment complemented by dCas9-CRISPR mediated tethering of these factors at
an active enhancer will be particularly informative for testing the necessity and sufficiency of each
factor in opposing enhancer-promoter looping.
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III. Other Mechanisms of Transcriptional Repression by Rev-erbα
Other aspects of transcriptional repression by Rev-erbα remain to be better understood.
The recent finding that Rev-erbα can also be recruited to the genome in a DBD-independent
manner by tethering to lineage-determine transcription factors has answered how tissue-specific
epigenomic rhythms are generated, but also raised new important questions (Zhang et al., 2015,
2016). For instance, how Rev-erbα becomes tethered to other transcription factors requires
further structural and biochemical studies. These studies will also address how Rev-erbα recruits
the NCoR-HDAC3 complex at the tethered sites despite the lack of RevDR2 or two adjacent
RORE motifs.
In addition, the perspective by de Lima and Göndör raised new questions related to our
finding (de Lima and Göndör, 2018). For instance, how the repressive action of Rev-erbα is
selectively permissive at engaged sites but somehow buffered against at passive sites is an
interesting question but also a perplexing one. Indeed, this question of why there are often more
binding sites than regulated sites for any given transcription factor is a longstanding conundrum in
the transcription field. One potential clue to this puzzle may lie in the composition of local
chromatin landscapes at enhancers. In our study, de novo motif analysis revealed that engaged
sites are enriched with DNA motifs known to be bound by Rev-erbα either directly (RORE and
RevDR2) and indirectly (HFN6), whereas passive site showed no such motifs. However, passive
sites were enriched with other nuclear receptor motifs (NR2F2 and RXR), which also contain the
core hexameric sequence AGGTCA but without a 5’ A/T rich flank. Therefore, one possibility is
that, as Rev-erbα scans through open chromatin regions, it may stall at the core hexameric
sequences but is unable to repress in the absence of the 5’ A/T rich flanks. In other words, the
recognition of a specific sequence may license the function of Rev-erbα, potentially through a
conformational switch mechanism similar to how the LBDs of NRs are reconfigured upon ligand
binding. While this idea may not sufficiently explain how Rev-erbα acts as a repressor at tethered
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sites, a similar notion may still be applicable in a sense that tethering to certain transcription
factors in permissive chromatin environments may enable the repressive action of Rev-erbα.
Another interesting question proposed in the perspective is how metabolism may help
reorganize the genome. This question is especially relevant to NR biology. Since many
metabolites are ligands for NRs, it is possible that NRs mediate crosstalk between metabolism
and 3D genome organization by binding to their ligands and bringing co-regulators to dynamically
fold and unfold enhancer-promoter loops, as exemplified by Rev-erbα in the context of circadian
rhythms in our study. One particularly attractive model to test this idea is a mouse model of
hyper-thyroid and hypo-thyroid states (You et al., 2010). By experimentally adjusting the serum
level of thyroid hormones, we can directly control the transcriptional activity of thyroid receptors
and measure their effects on enhancer-promoter loops, which will not only validate the biological
significance of dynamic enhancer-promoter looping, but will also broaden the applicability of our
model as a general mechanism of action by NRs.
Finally, there is an emerging understanding that the genome is biophysically
compartmentalized in distinct membraneless liquid states by phase separation (Hyman et al.,
2014). For instance, HP1 has been shown to compact the genome by phase separating
heterochromatin compartments into larger condensed droplets (Larson et al., 2017; Strom et al.,
2017). Also, several studies have reported that many transcription factors and proteins involved in
transcription contain intrinsically disordered regions (IDRs) required for the formation of phaseseparated compartments (Banani et al., 2017; Harlen and Churchman, 2017; Tatarakis et al.,
2017; Wright en Dyson, 2014). A few groups have further extended this finding and proposed that
phase separation also drives the formation of enhancer-promoter loops and transcriptional
activation (Hnisz et al., 2017). Intriguingly, they implicate BRD4 and the Mediator complex as
critical components of active phase-separated transcriptional compartments. In many aspects,
their model is consistent with our finding that Rev-erbα disrupts enhancer-promoter loops by
locally evicting BRD4 and MED1. Taken together, these findings generate an exciting new
hypothesis that Rev-erbα potentially represses transcription by dissolving phase-separated
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compartments. In the future, it will be particularly informative to utilize high-resolution live imaging
techniques to examine how phase separation influences transcription, and also how Rev-erbα
controls such phase separated compartments, both as an experimental subject and a biological
tool to probe into the general mechanism of transcriptional regulation.
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IV. Mechanisms of Circadian Transcriptional Activity of GABPα
One major unanswered question in our work on GABPα is how its transcriptional activity
appears to be circadian despites its constitutive genomic occupancy. There are several
possibilities for this observation. First, the most obvious answer is that GABPα recruits coactivators in a circadian manner. Interestingly, PGC1α is a well known co-activator of GABPα and
has been shown to be expressed in a circadian manner at the protein level in the liver, with a
peak in the same ETS phase around ZT0-3 (Handschin et al., 2007; Liu et al., 2007; Mootha et
al., 2005). Moreover, PGC1α has been known to regulate various aspects of mitochondrial
functions (Finck and Kelly, 2006). However, while this is an attractive hypothesis, one major
caveat of this model is that PGC1α knockout does not phenocopy the pathology seen in GABPα
L-KO (Lin et al., 2004). One possible explanation for this difference is that the lack of PGC1α may
be compensated by other functionally redundant PGC1α-like co-activators, such as PGC1β and
PPRC1 (Finck and Kelly, 2006).
Another possibility for the circadian transcriptional activity of GABPα is regulation by
post-translational modifications (PTM). For instance, GABPβ1 has been shown to be
phosphorylated by Lats1 involved in the Hippo pathway, which inhibits GABPβ1 transcriptional
activity by preventing nuclear translocation (Wu et al., 2013). Also, GABPβ1 has been shown to
be deacetylated by SIRT7, which enables its interaction with GABPα (Ryu et al., 2014). Finally,
ROS has been shown to interfere with the heterodimerization of GABPα and GABPβ (Niopek et
al., 2017). Given all of these findings, it will be important to examine how these proteins are
regulated by various post-translational mechanisms. One feasible experimental approach is to
utilize NEAT (Nuclear Extraction Affinity Tag) ChIP-MS method developed in the lab. By replacing
an endogenous gene with an exogenous gene construct fused to an affinity tag, a protein of
interest can be efficiently immunoprecipitated in a large quantity, which is often required for PTM
discovery by mass spectrometry analysis. More specifically, the endogenous GABPA gene will be
knocked out by AAV8-TBG-Cre and HA-tagged GABPα will be expressed from AAV8-TBG-
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GABPA-HA virus. This feasible approach will help identify both co-activators and PTMs that may
confer a circadian rhythm to GABPα transcriptional activity.
Another potential explanation for its circadian activity is regulation by its neighboring
proteins. It is possible that GABPα is not directly controlled, and instead other transcription
factors with circadian activities may rhythmically bind to the same cis-regulatory regions occupied
by GABPα. If that is the case, their putative DNA binding motifs should have been identified in the
previous de novo motif analysis of ZT0-3 circadian enhancers, but it is possible that their motifs
could have been masked if they are highly represented and common in the liver. A feasible
experimental approach to test this idea is to utilize ChIP-SICAP (Selection Isolation of ChromatinAssociated Proteins), which will identify local neighboring proteins and histone PTMs as well as
co-regulators (Rafiee et al., 2016). Moreover, this method can be further improved by replacing
the endogenous GABPα with HA-tagged GAPBα as proposed for the NEAT ChIP-MS method.
Together, NEAT ChIP-MS and ChIP-SICAP will complementarily yield a mechanistic insight into
how nascent transcription is circadian at the GABPα cistrome despite its constitutive genomic
occupancy.
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V. Hepatic Functions of GABPα and Its Role in Senescence Pathology
Several papers have previously investigated the role of GABPα in the mouse liver. They
have demonstrated that GABPα is implicated in the Hippo pathway and antioxidant defense as
well as AMPK-mediated inflammatory responses and cholesterol metabolism (Niopek et al., 2017;
Wu et al., 2013). While these findings are important, many of the observed changes in gene
expression were not seen in our datasets. Moreover, their physiological phenotypes were
different from those seen with our GABPα L-KO. One major discrepancy between our system and
their systems is that they used knockdown whereas we used liver-specific genetic knockout.
While their knockdown was relatively efficient, GABPα was not completely depleted in their
systems. Therefore it is very possible that different dosages of GABPα may lead to different
patterns of gene expression as well different physiological phenotypes. Such discrepancy can be
addressed from our end by utilizing AAV8-TBG-shRNA virus to knock down GABPα.
Alternatively, we can also inject AAV8-TBG-Cre to GABPα

fl/+

heterozygous mice and test if their

findings can be recapitulated in the context of partial genetic depletion of GABPα.
Our studies have provided several lines of evidence that mouse livers genetically lacking
GABPα assumed several key aspects of cellular senescence in terms of cell size, mitochondrial
defects, and patterns of differential gene expression. However, this senescence pathology needs
to be better characterized phenotypically and mechanistically. For instance, cellular swelling will
be distinguished from increased cellularity or mass by measuring dry liver weight. Furthermore,
hepatocytes lacking GABPα will be tested for senescence-associated β-galactosidase (SA-β-gal)
activity, which has been classically observed in senescent cells (Debacq-Chainiaux et al., 2009;
Dimri et al., 1995). While SA-β-gal activity has also been shown to be neither necessary nor
sufficient for senescence development, its will provide additional support for our finding (Lee et
al., 2006).
A recent study has identified a novel molecular link between DNA damage and
inflammation, both of which are characteristic features of senescence. Their model proposed that
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DNA damage produces cytoplasmic chromatin fragments, which pathologically triggers the
cGAS-STING pathway normally activated upon the immuno-detection of viral DNA, thereby
constitutively inducing the expression of downstream pro-inflammatory SASP genes (Dou et al.,
2017). We will first look for cytoplasmic chromatin fragments by DAPI staining. We will perform
immunohistochemistry for phospho-p53 and γH2AX as markers of cell cycle arrest and DNA
damage, respectively. These experiments together will further establish the presence of DNA
damage that potentially contributes to senescence pathology.
Our current model proposes that primary defects driving the senescence phenotypes lie
in mitochondrial dysfunction caused by GABPα L-KO. More specifically, we identified TYMP as a
candidate circadian gene directly controlled by GABPα, and putatively attributed the temporal
progression of senescence to the loss of its expression in GABPα L-KO. To test this model, we
will compare the plasma concentration of dThd and dUrd in both control and GABPα L-KO mice.
We will also examine whether the lack of TYMP expression causally drives senescence by reintroducing Tymp expression by injecting AAV8-TBG-Tymp virus in the background of GABPα LKO, with the expectation that ectopic Tymp expression will rescue the senescence phenotype.
However, it is also possibly that TYMP may not be primarily responsible for the
phenotype, as GABPα is known to regulate a large cohort of other mitochondrial genes. In our
model, we proposed that mitochondrial dysfunction leads to an increase ROS level, which
damages DNA and drives cellular senescence. Therefore, to test whether ROS is directly
responsible, we will perform both gain of function and loss of function studies by administering
oxidative agents or antioxidants and test if the senescent phenotype by GABPα L-KO mice is
worsened or improved, respectively. In addition to examining gross and histological changes, we
will also molecularly characterize the effect of these agents on other aspects of senescence, such
as DNA damage by γH2AX by immunohistochemistry and SASP gene expression by qPCR.
These experiments proposed here will not only better delineate the molecular
characteristics of senescence observed in GABPα L-KO, but will also provide a mechanistic
insight to what is causally contributing to the development of the observed phenotype.
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VI. Concluding Remarks
In this thesis, we sought to address mechanisms by which circadian rhythms are
controlled by transcription. We investigated how Rev-erbα dynamically opposes enhancerpromoter loops to repress circadian gene transcription. We also investigated how GABPα
potentially serves as a novel circadian ETS factor to maintain hepatic physiology. These studies
provide a new glimpse into the molecular coordination of circadian rhythms, but our
understanding of how various parts of the molecular clock work together is still incomplete.
So where does future research on transcriptional regulation and circadian rhythms lie? A
lesson from the history of science may offer insight. Anton van Leeuwenhoek was a Dutch
th

merchant from the 17 century, a draper by training with no formal training as a scientist. As a
draper, he always desired to see the fine threads of fabrics with his eyes, but no magnifying
lenses were good enough to meet his need back then. So he took up a keen interest in lens
making and later became one of the finest lens crafters of his time. He used his optical lenses not
just to examine the quality of his fine fabrics, but also to look at literally everything he could get
his hands on—plants, insects, and even his own bodily fluids. To his amazement, he observed
through his lenses moving organisms so small that no one even saw or knew existed. Starting as
his obsessive hobby, his technical innovation led to the discovery of microorganisms and
subsequently opened a portal to the microscopic world that has continued to expand to this day.
How science evolves can be serendipitous but not non-random. The scientific questions
we ask are often informed by our prior knowledge and tested by tools available to us. As such,
science and technical advancements are inseparably complementary; technical advancements
offer new opportunities to ask unexplored questions or even orthogonally test what we already
know, which can further our knowledge and potentially lead to new technological improvements.
Fitting with this discussion, the recent development of super high-resolution and single-molecule
imaging has enabled us to look at the spatiotemporal dynamics of transcription in real time.
Similarly, CRISPR-Cas9 has enabled not only genome-editing but also locus-specific tethering
and imaging at the spatial resolution that has not been possible in the past. New advances like
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these are critical for not just revisiting our longstanding questions but also for creating new
exciting ones going forward. Indeed, with all these new tools and computational power available
to us now, we may be a few tik-toks away from truly understanding the molecular timekeeper that
has existed within us as an integral component of life on the Earth.
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CHAPTER 5: Materials and Methods
I. In vivo studies
Animal studies: Male wild type C57/BL/6 mice (from JAX) were used in this study. The Nr1d1
(Rev-erba) knockout mice were obtained from B. Vennström, and have been backcrossed to the
C57BL/6 background for more than seven generations (Feng et al., 2011). All of the experiments
were performed with male mice aged between 8-12 weeks. Mice were housed in a temperaturecontrolled, specific-pathogen free facility with a 12-12 light on-and-off cycle (light on at 7AM/ZT0
and off at 7PM/ZT12). All animal studies were carried out in concordance with an approved
protocol from Institutional Animal Care and Use committee at Perelman School of Medicine at the
University of Pennsylvania. GABPα

fl/fl

mice were given as a kind gift from Steve Burden (NYU)

(Jaworski et al., 2007).

Gene transduction in mouse liver: Adeno-associated viruses encoding FLAG-tagged Rev-erba
or GFP under the liver-specific TBG promoter (AAV8-TBG-Rev-erba-F, and AAV8-TBG-eGFP
used as a negative control) were prepared by the Vector Core of the Penn Diabetes Research
Center, as described previously (Fang et al., 2014). 5e11 virus particles were injected into each
mouse by tail-vein injection, 2 weeks after which mice were harvested for analysis. To generated
GABPα L-KO, AAV8-TBG-Cre virus was used.

Isolation of hepatocyte nuclei: Mouse liver tissue (100mg) was dounced with 15 mL of cold
swelling buffer (10mM HEPES, 2mM MgCl2, 3mM CaCl3) 10 times with piston A. After 20 min
incubation on ice, the homogenate was dounced again 20 times with piston B, after which
additional 15mL of cold swelling buffer was added. The homogenate was filtered through a
100mm cell strainer and spun at 400g in 4°C for 10 min. The supernatant was discarded, and the
pellet resuspended in 10mL of cold swelling buffer containing 10% glycerol. 10mL of cold lysis
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buffer (swelling buffer + 10% glycerol +1% Igepal) was slowly added with occasional vortexing.
After 5 min incubation on ice, 30mL of cold lysis buffer was added, after which it was spun down
at 600g in 4°C for 5 min. The supernatant was discarded and the pellet resuspended with 25mL
of cold lysis buffer and spun down at 600g at 4°C for 5 min again. The supernatant was
discarded, and the pellet contained isolated, undisrupted nuclei. For ChIP and Hi-C experiments,
these pure nuclei were crosslinked in 10 mL of PBS with 1% formaldehyde for 20 min at room
temperature and quenched with 1/20 volume of 2.5M glycine solution for 5 min. The crosslinked
nuclei were spun down at 600g at 4°C for 5 min, after which they were resuspended in Hi-C lysis
buffer (10mM Tris-HCl pH8, 10mM NaCl, 0.2% Igepal) and spun down at 600g in 4°C for 5 min
again. The supernatant was discarded, and crosslinked nuclei was used for ChIP and Hi-C.

II. Molecular techniques
Chromatin immunoprecipitation (ChIP): ChIP experiments were carried out as previously
described with a few changes (Feng et al., 2011). 1-5 million crosslinked nuclei were used per
immunoprecipitation. Nuclear extract were prepared by sonication in lysis buffer (50mM Tris-HCl
pH 8, 0.1% SDS, 10mM EDTA) using the Bioruptor (Diagenode) for a fragment range of 2001000bp. Chromatin was immunoprecipitated in ChIP buffer (50mM Tris-HCl pH 7.5, 140mM NaCl,
1mM EDTA, 1% Triton X-100, 0.1% NaDOC) using 5-10ug of antibody, and reverse crosslinked
overnight at 65°C in SDS buffer (50mM Tris-HCl, 10mM EDTA, 1% SDS, pH 8). DNA was
isolated using phenol/chloroform/isoamyl alcohol and second chloroform wash. Precipitated DNA
was used for quantitative PCR or further processed for ChIP-seq. The antibodies and primers
used for ChIP are listed in Table S1. GAPBα antibody from Santa Cruz (H-180) was used.

Quantitative PCR (qPCR): Quantitative PCR was performed with Power SYBR Green Mastermix
and the PRISM 7500 instrument (Applied Biosystems). Analysis was carried out using the
standard curve method. mRNA expression was normalized to the housekeeping Rplp0 gene.
Primer pairs used for ChIP-qPCR and RT-qPCR were listed in Table S1 and 2.
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ChIP-seq: ChIP-seq was performed as described (Zhang et al., 2015) with minor changes.
Precipitated DNA was amplified by Phusion High-Fidelity DNA polymerase (NEB M0530) and
processed according to the ChIP Sequencing Sample Preparation Guide by Ilumina. The
following reagents were used: adaptor oligos and indexed primers from Illumina, all enzymes
from New England Biolabs (NEB) and PCR purification and MinElute Kit from Qiagen. The
Functional Genomics Core (J. Schug and K. Kaestner) at the University of Pennsylvania
performed deep-sequencing using the Illumina HiSeq2000.

In situ Hi-C: In situ Hi-C was performed with mouse liver tissues using MboI restriction enzyme
according to the protocol described (Rao et al., 2014) with minor changes. Instead of crosslinking
cells directly, isolated and crosslinked hepatocyte nuclei were used. In addition, biotin from
unligated ends were removed by incubating 5ug of DNA in 50ul T4 DNA polymerase reaction
(0.1ug/ul BSA, 1xNEB buffer 2, 25uM dGTP, 15U T4 DNA polymerase). The reaction was carried
out at room temperature for 4 hours and stopped by the addition of 2ul of 0.5M EDTA pH 8.0 per
50ul reaction. Isolated Hi-C DNA was amplified by fewer than 8 PCR cycles to reduce PCR
duplicates. Hi-C library were quantified by KAPA library preparation kit (Roche) and BioAnalyzer
(Agilent). We note that, while genome organization in Drosophila is sensitive to temperature (Li et
al., 2015), Fig. S1B demonstrates reproducibility between the TAD boundaries we report in
mouse liver and previously identified TAD boundaries in mouse embryonic stem cells (7)
indicating that this technical issue likely does not have a major impact on our findings.

Chromatin conformation capture (3C): 3C experiments were carried out in the same manner
7

as Hi-C except for minor changes. 10 isolated and crosslinked nuclei were used per each 3C
experiment. HindIII enzyme was used instead of MboI. Biotin overhang fill-in step was omitted,
and in-nuclei ligation was performed immediately after digestion with HindIII. After ligation, the
supernatant was removed, the pellet containing nuclei resuspended in Hi-C lysis buffer and
residual HindIII enzymes were denatured by incubating at 65°C for 30 min. The nuclei were spun
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down for 5 min at 600g, after which the supernatant was discarded, and the pellet containing
nuclei was resuspended again in Hi-C lysis buffer. The nuclei were reversed crosslinked and
treated

with

proteinase

as

stated

in

the

Hi-C

protocol.

DNA

was

isolated

using

phenol/chloroform/isoamyl alcohol and second chloroform wash. Precipitated DNA was dissolved
in water, and 100ng of DNA was used for each technical replicate for quantitative PCR with
specific TaqMan probes. Standards were prepared using BAC (the CHORI BACPAC Resource
Center) spanning an entire locus to be probed. HindIII digested and randomly ligated DNA
fragments were diluted to 500ng/ml, 50ng/ml, 5ng/ml and used for 1000, 100, 10 arbitrary units
for standard curves, respectively. All interactions are normalized to the intragenic interaction at
the TBP locus to control for DNA amounts and crosslinking efficiency. The BAC, primers and
probes used are listed in Table S5.

Slides: Liver tissues were fixed in 1% formaldehyde overnight and dehydrated in 30%, 50%, 70$,
95% and 100% ethanol, each step for 2 hours. Paraffin sections, H&E and immunohistochemistry
slides were prepared by the Penn GI and CVI Core. Electron microscopy images were prepared
by the Penn Electron Microscopy Core

Western blot: western blots were performed according to the protocol described in the cited
reference (Papazyan et al., 2016b). GAPBα antibody from Santa Cruz (H-180) was used.

III. Bioinformatics and statistical analyses

ChIP-seq data processing: ChIP-seq data were processed as previously described (Zhang et
al., 2015). The reads from biological replicates were pooled and aligned to the mm9 mouse
genome. Browser tracks were processed by Homer v4.7 (Heinz et al., 2010) and peaks were
visualized on IGV (Robinson et al., 2011). High confidence Rev-erbα peaks were identified by
following parameters: two groups of peaks were called by FC 1.5> between ZT10 vs. ZT22
(physiological KO) and ZT10 vs. Rev-erbα KO (genetic KO). The overlapped peaks between
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these groups within 200bp were called as common peaks. The common peaks were further
filtered by > 2rpm cutoff, yielding 2402 high confidence unique Rev-erbα peaks. ChIP-seq
datasets are summarized in Table S3 and available in GEO (GSE104129). To identify high
confidence GABPα peaks, 3-fold change cutoff was used to call peaks in control compared to LKO.

GRO-seq data processing: GRO-seq data at ZT10 and ZT22 were downloaded (Fang et al.,
2014) and gene body transcription level was calculated by counting reads beginning 500 bp
downstream from the TSS in the strand where the gene is transcribed. Transcription tag counts
were normalized by Reads Per Kilobase of transcript per Million (RPKM).

De novo motif analysis: De novo motif finding was performed by Homer v4.7 (Heinz et al.,
2010). Motif discovery was performed with different motif lengths (8, 10, 12, 14,16, 18 and 20 bp).
As the search for motifs longer than 15 bp was set in this analysis, a number of 4 mismatches
has been allowed.

RNA-seq analysis: Trimmomatic was used to trim RNA-seq data(Bolger et al., 2014). After
mapping the trimmed data to mm9 using Hisat2, FPKM and read counts for each gene were
calculated using StringTie and FeatureCount, respectively (Kim et al., 2015; Liao et al., 2014;
Pertea et al., 2015, 2016). Differentially gene expression analysis was performed by edgeR, and
gene ontology (GO) analysis was performed using clusterProfiler (Robinson et al., 2009; Yu et al.,
2012).

Hi-C data processing: Deep-sequencing of Hi-C libraries were performed by the Functional
Genomics Core (J. Schug and K. Kaestner) at the University of Pennsylvania and the Penn
Epigenetics/Cell and Developmental Biology Sequencing Core using the Illumina NextSeq 75
cycle (40bp paired-end sequencing). The sequences were processed using Hi-C Pro (Servant et
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al., 2015). Singleton and multi-hits reads were discarded.

Each reported aligned pair was

assigned a restriction fragment according the restriction fragment coordinates that have been
created by digestion the genome using the MboI restriction enzyme. Invalid ligation products were
discarded and only valid pairs with two different ligation fragments were kept to build the contact
matrix after removing duplicated valid pairs. The built matrix included the inter- and intrachromosomal interaction reads for the specified resolutions. The genome was split into bins of a
specified size (5 kbps), and the reported valid pairs were associated to bins to form the
interaction raw matrix of that bin size. We have created matrices of different bin sizes to be used
in the analysis on the chromatin interaction. The raw matrices were normalized to correct for
biases using the ICE (Iterative correction of Hi-C data) (Imakaev et al., 2012) of Hi-C Pro. Hi-C
library statistics are summarized in Table S4.

Differential Analysis: Differential analysis between interaction matrices of two Hi-C libraries was
performed to highlight the difference between Hi-C interactions. We performed smoothing by
applying 2D Gaussian filter (σ=2.0) using window size 17x17, followed by sharpening to detect
and maintain edges of foreground regions. Background signals were masked for further
processing. For differential analysis of a pixel, a surrounding 5x5 window was compared between
the two matrices using t-test. If the p-value was significant, the center pixel of that window was
considered significantly different.

Enhancer-promoter loop calling using Rev-erbα peaks: To detect the interaction between
Rev-erbα peaks and the target genes, a 3x3 window was examined if at least 6 bins had an
interaction greater than or equal to a particular loop cutoff threshold after ICE normalization. In
this analysis, we used a loop cutoff of 10 (ICE normalized interaction value). If a loop included the
promoter of a gene repressed at ZT10 (FC ≥1.5 ZT22 GRO-seq/ZT1 -GRO-seq), the Rev-erbα
binding site was defined as “engaged”; otherwise, it was defined as “passive.”
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TAD and sub-TAD boundary calling: TAD calling was performed based on the directionality
index (DI) method described previously (Dixon et al., 2015). The TADs were called using the ICE
Hi-C matrix with 40 Kbps bin size and with upstream and downstream directionality index bias
within a 2 Mbps window. We also called the sub-TADs with different window sizes to detect
hierarchical TADs (TADs and sub-TADs). We used window sizes 150 kbps, 250 Kbps, 500 Kbps,
1Mbp, and 2 Mbps in the analysis. We used bin size 10 kbps Hi-C interaction matrices in this
hierarchical TADs calling.

Circadian sub-TAD analysis: Circadian sub-TADs have been defined as sub-TADs that include
genes transcribed with a circadian rhythm (6). Circadian genes were grouped based on their
phases (ZT0-3, ZT3-6, ZT6-9, ZT9-12, ZT12-15, ZT15-18, ZT18-21, and ZT21-24) (Fang et al.,
2014). We used genes from the ZT9-12 and ZT21-24 groups to match the time points for the HiC libraries. For each sub-TAD, differential analysis was performed between ZT22 and ZT10 ICEnormalized Hi-C matrices, which resulted in ZT22-specific and ZT10- specific intra-sub-TAD
interaction. The size-normalized sub-TADs were then averaged for each group of sub-TADs
(ZT9-12-specific and ZT21-24-specific groups). The averaged sub-TADs of each group were
converted into log2 scale for visualization.

TAD and sub-TAD boundary overlap: TAD overlap was determined by evaluating the
conservation of TAD boundaries among ZT22, ZT10, and mESC Hi-C libraries. After calling
TADs, the overlap between TAD boundaries of two or more different Hi-C libraries was performed
by checking locations of the 5’ end and 3’ end boundaries of the called TADs within a particular
tolerance distance (200 kbps).
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IV. Tables
Table S1. ChIP reagents
ChIP antibodies
Protein

Manufacturer

Catalog number

Rev-erbα

Cell Signaling

2124

CTCF

Millipore

07-729

RAD21

Abcam

ab992

MED1

Bethyl

A300-793A

BRD4

Bethyl

A301-985A100

ChIP-qPCR primers
Site

5' Forward

3' Reverse

Ins

GGACCCACAAGTGGAACAAC

GTGCAGCACTGA TCCACAA T

Cry1

TTCCTTATGCCACTTCCAAAA

ATGCTAAACCACCCACTGGT

Ppard

CAAATGGGAAGCAGCGAGTA

CCAGCTGCCCTATCAATCAG

Gldc

GGTGGCCTCAAAATACACAGA

GTGGAGACAACTCCTGCACA

Cplx

TCTACCTCTCCTACCCCAAGG

AGCCTGTTTCACAGGAAGGA

Elovl3

TCACAAAAGGTACAGAGCCAAA

CAGCCAGTTAATATCTCCCATTG

ChIP-qPCR primers for GABPα

Site

5' Forward

3' Reverse

ETS_eRNA1

GTAGAGAAAGGGGCGGAAAC

TCCCTGCTTGTTTTTCTGGA

ETS_eRNA2

CAGCCTGCAGGACAGACAGT

CGAGGAGGGCTGTAGAGAAG

ETS_eRNA3

GGGGAATCGTGAGACAGG

GCTCTGGGCTCGCAGTTC
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Table S2. mRNA expression qPCR reagent

mRNA qPCR primers

Gene

5' Forward

3' Reverse

Rplp0

TCCAGGCTTTGGGCA TCA

CTTTATCAGCTGCACATCACTCAGA

Cry1

AGCGCAGGTGTCGGTTATGAGC

ATAGACGCAGCGGATGGTGTCG

Gene

5' Forward

3' Reverse

Tymp

GGAAGAGCACAGGACACACA

CCCGAGTCAGCACAGATGTC

Il1a

CAAAGTTCCTGACTTGTTTGAAGAC

GCCATAGCTTGCATCATAGAAGGAT

Il1b

CCTGAACTCAACTGTGAAATGCC

CAGGACAGCCCAGGTCAAA

Ifit44

ATACTATTAGATGAGAAAGCTGTGATTG

TACTATGTAACACAGCAATGCCT

Ccl2

GCCTGCTGTTCACAGTTGC

TCATTGGGATCATCTTGCTG

Cxcl1

CTGGGATTCACCTCAAGAACATC

CAGGGTCAAGGCAAGCCTC

Cxcl2
Cxcl5

CCCCTGGTTCAGAAAATCATCC
TGGCATTTCTGTTGCTGTTC

TTTCTCTTTGGTTCTTCCGTTGAGG
AGCAAACACAACGCAGCTC
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Table S3. ChIP-seq library summary

Protein

Time

Replicates

CTCF

ZT22

2

CTCF

ZT10

2

RAD21

ZT22

2

RAD21

ZT10

2

MED1

ZT22

1

MED1

ZT10

1

MED1

ZT10 αKO

1

BRD4

ZT22

1

BRD4

ZT10

1

BRD4

ZT10 αKO

1

Rev-erbα

ZT22

2

Rev-erbα

ZT10

2

Rev-erbα

ZT10 αKO

2

Protein

Time

Replicates

GABPα WT

ZT1

3

GABPα KO

ZT1

3

GABPα WT

ZT13

2

GABPα KO

ZT13

2

GABPβ1/2
(GABPα WT)

ZT1

1

GABPβ1/2
(GABPα KO)

ZT1

1

GABPβ1/2
(GABPα WT)

ZT13

1

GABPβ1/2
(GABPα KO)

ZT13

1
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Table S4. Hi-C library summary

ZT22 Hi-C unique valid read pair distribution
valid_interaction

670515102

trans_interaction_all

265634607

cis_interaction_all

404880495

cis_shortRange (<20kbp)

151469116

cis_longRange (>20kbp)

253411379

Biological replicates

5

ZT10 Hi-C Unique valid read pair distribution
valid_interaction

660903704

trans_interaction_all

247967408

cis_interaction_all

412936296

cis_shortRange (<20kbp)

185241695

cis_longRange (>20kbp)

227694601

Biological replicates =

2

αKO Hi-C Unique valid read pair distribution
valid_interaction

539690196

trans_interaction_all

225494937

cis_interaction_all

314195259

cis_shortRange (<20kbp)

120205453

cis_longRange (>20kbp)

193989806

Biological replicates =

3
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Table S5. 3C reagents

Bacterial artificial chromosome for Cry1
RP23-381A6
Cry1 probe sequence (5’-3’)
GGATGTGCCGGCAAGTTGGT

Cry1 locus primers
Primer

Sequence (5'-3')

Note

Cry1_constant_F

AGCTCTTTTTGTTCCGCTCA

Constant primer

Cry1_1R

CCCATTCCTCTCCTTGTTCC

Cry1_2R

GCTCTGAAACCACTTGCTCA

Cry1_3R

CATGGAAGCTGTTAATTTCACTTG

Cry1_4R

TCGGCAGCTTTTTACACTGA

Cry1_5R

GTCGCAGGACCTCAAATTCA

Cry1_6R

AATGCCCCTTGTCTGCATTA

Cry1_7R

CACAGGGCAAGCCTTTCTT

Cry1_8R

CAAAGTCTGAGCCCAGTCAC

TBP probe sequences (5’-3’)
TGGCTCCTCCCCTTTGAGATTTG
TBP primers
Primer

Sequence (5'-3')

TBP_constant_F

CATCTACTGAGAACATGATGAGGA

TBP_1R

CCCAAATAGTGTTGTCTGCAA
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Used for E-P loop
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